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ABSTRACT 
In eukaryotic cells, the mevalonate pathway of isoprenoid biosynthesis provides 
the cell with essential precursors for several cellular processes. For example, one 
product, FDP (farnesyl diphosphate) is a fundamental precursor for sterol 
biosynthesis and it is also used for protein prenylation.  In the slime mould 
Dictyostelium discoideum some of the mevalonate pathway enzymes possess a 
peroxisomal targeting signal. This suggested that part of the mevalonate pathway 
may take place in the peroxisomes.  
 
In this study, the intracellular locations of the mevalonate pathway enzymes were 
investigated by transforming D. discoideum amoebae to express each enzyme as a 
fusion protein with either GFP (green fluorescent protein) or mRFP (monomeric 
red fluorescent protein). It was found that three of the mevalonate pathway 
enzymes are peroxisomal: 3-hydroxy-3-methylglutaryl-coenzyme A synthase 
isozyme B, phosphomevalonate kinase and farnesyl diphosphate synthase. HMG-
CoA reductase is associated with the endoplasmic reticulum and the other four 
enzymes of the mevalonate pathway were most likely to be in the cytosol: HMG-
CoA synthase isozyme A, mevalonate kinase, diphosphomevalonate 
decarboxylase and IDP-isomerase.  
 
The intracellular location of the first five enzymes involved in sterol biosynthesis 
from farnesyl diphosphate was also identified by using the GFP or mRFP tagged 
enzyme approach. Some of these enzymes possess a strong peroxisomal targeting 
signal type 1 (PTS1). It was shown that the first four enzymes of the pathway: 
squalene synthase, squalene epoxidase, oxidosqualene cyclase and cycloartenol -
C-24-methyltransferase are peroxisomal whereas the two isozymes of the fifth 
enzyme, methylsterol monooxygenase, are associated with the endoplasmic 
reticulum.  
 
It was also demonstrated that the first four enzymes on the sterol biosynthesis 
pathway are strongly associated with the peroxisomal membrane. However, the 
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putative PTS1 present at the C-terminus of squalene synthase, oxidosqualene 
cyclase and cycloartenol-C-24-methyltransferase would imply that each of these 
enzymes should be a peroxisomal matrix protein. We therefore investigated 
whether the putative PTS1s are involved in directing these three enzymes into the 
peroxisomes. It was found that squalene synthase was largely peroxisomal even 
when its PTS1 was absent but the PTS1 in oxidosqualene synthase and 
cycloartenol-C-24-methyltransferase was essential for entry of these enzymes into 
peroxisomes.  
It appears that the sterol biosynthesis in D. discoideum is unusual since the 
enzymes squalene synthase, squalene epoxidase, oxidosqualene cyclase and 
cycloartenol -C-24-methyltransferase are accumulated in the peroxisomes whereas 
in all other organisms studied they are in the endoplasmic reticulum. 
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Chapter1 
Introduction 
 
Peroxisomes were discovered over 50 years ago by a Swedish PhD student 
Rhodin (1954).  They were characterized as enclosed organelles surrounded by a 
single membrane. Later on, further biochemical studies were carried out by the 
group of De Duve (1966) in order to investigate the peroxisomal enzymes that 
may be involved in cellular metabolisme. Recently around 50 peroxisomal 
enzymes have been identified which are involved mainly in producing hydrogen 
peroxide and the degradation of fatty acids by -oxidation. 
 
Peroxisomes have attracted the interest of scientists because it was realised there 
is a connection between peroxisomal function deficiency and several human 
diseases. For example, the entire absence of peroxisomes leads to a severe disease 
such as Zellweger-syndrome (ZS) in which the child dies in his first year. A 
defect in multiple peroxisomal functions can also lead to less severe diseases such 
as neonatal  adrenoleukodystrophy (NALD) and Infantile Refsum’s disease (IRD) 
in which the patients may survive into adulthood (Steinberg et al., 2006, Wanders 
and Waterham, 2006). Attempts to understand these genetic diseases were started 
in humans but these genes are conserved also in the yeast Saccharomyces 
cerevisiae and other yeast species. Therefore, it has been convenient to use yeast 
as a model system due to the ability of yeast to grow in different conditions, and 
even in the absence of peroxisomes. Furthermore, genetic studies in yeast are 
easier to perform than in human cells. 
 
Despite many investigations, some suggested roles for the peroxisome remain 
controversial. In particular, it has been unclear whether the enzymes of the 
mevalonate pathway of isoprenoid metabolisme are peroxisomal. However, it has 
been established recently in the slime mould Dictyostelium discoideum that the 
final enzyme, farnesyl diphosphate synthase, of the mevalonate pathway is 
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peroxisomal (Nuttall et al., 2012). This led to the idea of using Dictyostelium 
discoideum to investigate whether any of the other enzymes on the pathway are 
peroxisomal. 
 
It was also noticed that the enzyme squalene synthase that converts two molecules 
of farnesyl diphosphate, the first committed enzyme of sterol biosynthesis, 
appeared to have a peroxisomal targeting signal. Investigations were therefore 
also carried out to determine whether peroxisomes are involved in sterol 
biosynthesis in D. discoideum.  
 
This thesis describes the results of these investigations of the mevalonate pathway 
and sterol biosynthesis. 
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1.1  Peroxisomes 
Peroxisomes (microbodies, glyoxysomes, glycosomes and Woronin-bodies), are 
single membrane organelles present in almost all eukaryotic cells. They appear as 
spherical structures ranging from 0.1 to 1μm in diameter. Based on the organism 
and cell type peroxisomes can carry out a wide variety of  biochemical reactions 
(Lazarow and Fujiki, 1985).                                                                                        
Rhodin (1954) was one of the first researchers who described peroxisomes, 
initially termed microbodies. Based on electron micrographs of mouse kidney 
cells, peroxisomes were described as organelles enclosed in a single membrane. In 
the mid sixties de Duve and Baudhuin began to study peroxisome biochemistry. 
They managed to separate  the peroxisomes from other cells organelles by density 
gradient centrifugation and found that the newly identified organelle contains 
several enzyme such as D-amino acid oxidase, urate oxidase and catalase. The 
peroxisome is so-called because of the role of catalase in the breakdown of 
hydrogen peroxide (Baudhuin et al., 1965, De Duve and Baudhuin, 1966).  
About 50 enzymes have since been found within peroxisomes which play an 
important role in a variety of biochemical pathways. Mainly they are involved in 
reactions producing hydrogen peroxide of which degradation of long-chain fatty 
acids is particularly important.  In mammalian cells, two -oxidation pathways 
occur in the peroxiomes in addition to the fatty acids α-oxidation which 
responsible of the degradation of a special group of lipids comprising very long 
straight chain fatty acids (VLCFA), long chain dicarboxylic acids,  branched-
chain fatty acids. These lipids cannot be oxidized by the mitochondrial -
oxidation pathway (Brown and Baker, 2003). By contrast, in fungi and plants, the 
fatty acid -oxidation pathway is restricted to the peroxisomes (Poirier et al., 
2006). Furthermore, in mammals peroxisomal enzymes can be involved in various 
activities such as the synthesis of ether lipids (plasmalogens), cholesterol and bile 
acids and in breakdown of reactive oxygen species (Brown and Baker, 2008, 
Rucktaschel et al., 2011).  
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In plants, different types of peroxisomes have been identified. One such type 
termed glyoxysomes exists in germinating seeds. Glyoxysomes are involved in 
the glyoxylate cycle by which fatty acids stored in the seeds are converted into 
sugars. Other types of  peroxisomes were found in plant leaves supporting the 
mitochondrial  photorespiration (Brown and Baker, 2003). In addition, plant 
peroxisomes are involved in many biochemical processes such as producing 
hormones such as jasmonates (phytohormones),  indole-3 acetic acid, reactive 
oxygen species and the catabolism of some branched chain amino acids, purines 
and polyamines (Platta and Erdmann, 2007a, Brown and Baker, 2008).                  
                                                                                            
Specific types of peroxisomes, considered initially to be different organelles, have 
been investigated. In this context,  Woronin-bodies of filamentous fungi were 
identified as a special form of peroxisome (Baker and Sparkes, 2005). They have 
role in repairing the septal pores of damaged hyphae in order to avoid cytosolic 
bleeding (Platta and Erdmann, 2007b). Furthermore, glycosomes present in 
parasitic protozoa Trypanosoma, contain the key enzymes of glycolysis and are 
considered to be a type of peroxisome.                                             
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1.2 Peroxisomal diseases 
Peroxisomes have attracted considerable attention owing to the association of 
peroxisomal deficiency or malfunction with several genetic disorders. 
Peroxisomal disorders can be classified into two categories (I) Peroxisomal 
biogenesis disorders (PBDs) and (Π) Single peroxisomal enzyme deficiencies 
(PEDs). PBDs give the most severe clinical symptoms and are caused by a 
deficiency in more than one peroxisomal function (Fujiki, 2000). The other group 
of PEDs is linked to a defect in a single peroxisomal function (Steinberg et al., 
2006, Wanders and Waterham, 2006). 
 
The PBDs consist of cerebro-hepato-renal sydrome, usually known as Zellweger-
syndrome (ZS), neonatal adrenoleukodystrophy (NALD), infantile Refsum’s 
disease (IRD) and rhizomelic chondrodysplasia punctata (RCDP). The first three 
syndromes (ZS, NALD and IRD) are sub-grouped as Zellweger spectrum 
syndrome (ZSDs) because mutation within the same gene can lead to these 
disorders. Zellweger-syndrome is characterized by deficiency in the import of 
peroxisomal matrix proteins and by the decreased number of peroxisomes. ZS is 
considered to be the most severe form of PBD and is associated with a wide range 
of abnormalities such as craniofacial and eye abnormalities, severe hypotonia and 
neuronal migration defects causing brain dysfunction (Steinberg et al., 2006). 
NALD and IRD are classified as less severe PBD syndromes. Therefore, patients 
affected by moderate NALD and IRD may survive to adulthood. These disorders 
are characterized by craniofacial abnormalities similar to the ZS facial features 
though less severe, liver diseases, seizures, physical weakness and   learning 
disabilities (Wanders and Waterham, 2006). 
  
The second group PEDs is caused by a deficiency of one  peroxisomal function 
such as -oxidation or -oxidation of fatty acid, ether phospholipid biosynthesis  
and glyoxylate detoxification (Wanders and Waterham, 2006).   
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1.3  Peroxisome Biogenesis (Peroxins/PEX genes) 
The essential genes for peroxisome biogenesis were identified in the late 1980s 
based on observation in Saccharomyces cerevisiae. These indicated that growth 
on oleic acid can increase the number of peroxisomes in yeast cells (Veenhuis et 
al., 1987). Furthermore, it has been shown by Erdmann and his colleagues that 
functional peroxiomes are essential for S.cerevisiae to grow on oleic acid as a sole 
carbon source (Erdmann et al., 1989). Later on, this approach was adopted as a 
fundamental basis for genetic screening in order to detect mutants deficient in 
peroxisome biogenesis i.e. strains deficient in peroxisome biogenesis grow in 
media containing glucose but not in media in which oleate is the sole carbon 
source.                                                                                                                 
In mammals, further genetic screens have been carried out utilizing Chinese 
Hamster Ovary (CHO) cells, in which peroxisomes are essential for plasmalogen 
synthesis. This study provided a crucial tool for the  identification of  a further 
mutation that affected peroxisomal assembly (Tsukamoto et al., 1990). A number 
of important genes for peroxisome biogenesis have also been identified by a 
complementation assay in S. cerevisiae and CHO peroxisome-deficient mutants 
(Erdmann et al., 1989, Tsukamoto et al., 1990). Investigations using a similar 
genetic approach were also performed in various yeast species such as Hansenula 
polymorpha, Pichia pastoris and Yarrowia lipolytica (Gould et al., 1992, Liu et 
al., 1992).                                     
Proteins essential for peroxisome function are called peroxins and are encoded by 
the PEX genes. Distel et al (1996) have given a summary of the PEX genes that 
have been identified in various organisms. This term referred to their function in 
peroxisome biogenesis and the import of peroxisomal matrix and membrane 
protein (Distel et al., 1996).                                                                                                           
Recently, a novel approach in biological sciences has been developed supporting 
the identification of a new peroxins. This approach consists of proteomic assays 
and DNA microarray screens for oleic-acid-induced yeast genes. Nowadays, up to 
32 PEX genes have been demonstrated (Table 1.1) (Smith et al., 2002, Tam et al., 
2003, Vizeacoumar et al., 2003, Vizeacoumar et al., 2004).                                                                                                   
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Table 1.1: Peroxins 
Peroxin 
 
General and Molecular Function 
 
Pex1 Matrix protein import ( AAA-ATPase required for the recycling of Pex5) 
Pex2 Matrix protein import (Ring-finger protein) 
Pex3 de novo synthesis+ Membrane docking factor for Pex19p 
Pex4 Matrix protein import (E2-enzyme required for mono-ubiquitination and 
recycling of Pex5) 
Pex5 Matrix protein import (PTS1-Receptors) 
Pex6 Matrix protein import (AAA-ATPase required for the recycling of Pex5) 
Pex7 Matrix protein import (PTS receptor) 
Pex8 Matrix protein import (Connect between the docking and the RING) 
Pex10 Matrix protein import (RING-finger protein, links Pex4 to the 
importomer) 
Pex11 Involved in proliferation 
Pex12 Matrix protein import (Required for Pex5 recycling) 
Pex13 Matrix protein import (Involved in receptor docking) 
Pex14 Matrix protein import (Involved in receptor docking) 
Pex15 Membrane anchor for Pex6 
Pex16 Peroxisome biogenesis 
Pex17 Matrix protein import + Peroxisome biogenesis 
Pex18 Matrix protein import (Import of PTS2) 
Pex19 de novo synthesis + Import of PMPs 
Pex20 Matrix protein import (PTS2 co-receptor in fungi) 
Pex21 Matrix protein import (PTS2 co-receptor in yeast) 
Pex22 Matrix protein import (Membrane anchor for Pex4) 
Pex23 Matrix protein import in Yarrowia lipolytica 
Pex24 Required for peroxisome assembly in Yarrowia lipolytica 
Pex25 Regulate size and maintenance 
Pex26 Matrix protein import (Membrane anchor for Pex6 in human cells) 
Pex27 Regulate size and number 
Pex28 Regulate size and number 
Pex29 Regulate size and number 
Pex30 Regulate size and number 
Pex31 Regulate size and number 
Pex32 Regulate size and number 
Pex36 Regulate size and number 
 Proteins present in S.cerevisiae 
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1.4 Peroxisomal matrix protein import pathway 
It is well known that the peroxisome does not contain any DNA and therefore 
peroxisomal matrix proteins are encoded by the nuclear genome and, after 
synthesis in the cytosol by free polyribosomes, are imported post-translationally 
into peroxisomes (Rucktaschel et al., 2011, Fujiki, 2000).                                                                                                                       
The pathway for importing the matrix proteins into the peroxisome consists of 
four distinct steps (Figure 1.1): targeting signal and cargo interaction; receipt of 
the cargo by the docking complex in the peroxisomal membrane; translocation 
into the peroxisome and release of the cargo. Finally, recycling of the receptor 
occurs (Brown and Baker, 2008).                                                                                                         
The sorting of the peroxisomal matrix proteins from the cytosol into the 
peroxisomal matrix requires a peroxisomal targeting signal (PTS). There are two 
types of PTS: Peroxisomal targeting signal type 1 (PTS1) is the major signal that 
is used by the peroxisomal matrix proteins. This signal is located at the extreme 
carboxy- terminus and comprises a (S/A/C) (K/R/H) (L/M) tripeptide  consensus 
sequence (Gould et al., 1989). The -SKL tripeptide sequence has been described 
as the strongest PTS1 in various organisms (Petriv et al., 2002).                                                                                                                                   
By contrast, a few matrix proteins are targeted by  the peroxisomal targeting 
signal type 2 (PTS2), which comprises the (R/K)-(L/V/I)-X5-(Q/H)-(L/A) (where 
X can be any amino acid) consensus sequence placed near to the N-terminus 
(Rachubinski and Subramani, 1995). More recent analysis of functional PTS2 
sequences has suggested that the consensus sequence should be redefined as –
R(L/V/I/Q)XX(L/V/I/H)(L/S/G/A)X(H/Q)(L/A) which represents the most 
common variant of the PTS2, whereas (R/K) (L/V/I/Q)XX(L/V/I/H/Q) 
(L/S/G/A/K)X(H/Q) (L/A/F) sequences characterize essentially all variants of 
PTS2 (Petriv et al., 2004). The import of peroxisomal matrix proteins based on 
using either the PTS1 or PTS2 pathway differs among organisms. For example, in 
plants the number of matrix proteins using the PTS2 pathway is greater than in 
mammals and yeast (Reumann et al., 2009). However, the nematode 
Caenorhabditis elegans uses only the PTS1 pathway (Motley et al., 2000). 
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In the cytosol the newly synthesised proteins with a PTS1 or a PTS2 need a 
receptors to transfer them into the peroxisomal matrix. There are two soluble 
cytosolic receptors termed Pex5 and Pex7 that recognise PTS1- and PTS2- 
containing proteins respectively (Fujiki, 2000, Rachubinski and Subramani, 
1995). Pex5 has a C-terminal domain (six tetratricopeptide repeats TPRs) 
providing the proper direct PTS1- binding site (Stanley et al., 2006). By contrast, 
Pex7 needs to be associated with other cytosolic co-receptors to allow  import of 
the PTS2-containg proteins into the peroxisome. These co-receptors vary between 
different organisms. In S.cerevisiae  they are Pex18 and Pex21, in fungi, Pex20. 
The co-receptor in mammals is the long version of Pex5 (Pex5pL) (Purdue et al., 
1998, Titorenko et al., 1998, Otera et al., 2000).                                                                                                                    
Once the PTS-receptors have bound to their targets in the cytosol they interact 
with different complexes of peroxisomal membrane proteins, comprising the 
docking-complex and the RING (finger)-complex. The docking-complex includes 
three proteins Pex13, Pex14 and, in S. cervisiae, Pex17.                                                                                                                                            
Pex13 is described as a peroxisomal integral membrane protein having a C-
terminus Src-homology-3 (SH3) domain which interacts with pex5 in the cytosol 
(Erdmann and Blobel, 1996, Rayapuram and Subramani, 2006). The N-terminal 
domain of Pex13 also faces the cytosol and interacts with Pex7 and Pex14 (Stein 
et al., 2002). Pex14 can also bind Pex5, Pex7 and Pex17. In cells of higher 
eukaryotes, Pex17 is absent. However, it has been suggested that Pex17 
cooperates in the docking process due to its interaction with Pex14. Thus, the role 
of  Pex17 remains to be elucidated (Kiel et al., 2006, Rucktaschel et al., 2011). 
The docking complex  interacts with the RING-complex, comprising Pex2, Pex10 
and Pex12, by the intra peroxisomal protein Pex8 in order to form a multi- 
proteins- complex termed the importomer (Agne et al., 2003).                                                                                                                        
Following the docking process, the peroxisomal matrix protein must have to cross 
the peroxisomal membrane. However, the machinery by which the proteins 
translocate into the peroxisomal matrix is not fully understood. Interestingly, 
although Pex5 is known as a soluble cytosolic protein, it can behave also as 
integral membrane protein upon interaction with the peroxisomal membrane 
(Gouveia et al., 2000). In this context, three hypotheses have been suggested to 
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describe the protein translocation machinery. First, the shuttle hypothesis proposes 
that the PTS-receptor is associated with the peroxisomal membrane surface and 
delivers its cargo without entering into the peroxisomal matrix (Dammai and 
Subramani, 2001, Nair et al., 2004). Secondly, the extended shuttle hypothesis 
suggests that  the whole PTS-receptor complex reaches the peroxisomal matrix 
and then releases the cargo (Kunau, 2001, Smith and Schnell, 2001). The third 
hypothesis claims that the PTS-receptors join together with the co-receptors to 
form an import pore in order to open the membrane upon loading the cargo 
(transient pore hypothesis) (Erdmann and Schliebs, 2005).                                                                                                                                             
The mechanism by which the PTS-receptor releases its cargo into the peroxisomal 
matrix is still not clear. However, it has been suggested that Pex8 has a role in this 
event (Rehling et al., 2000). Following release of the cargo Pex5, Pex7 and Pex20 
need to be recycled back to the cytosol to interact again with a new target 
(Dammai and Subramani, 2001, Nair et al., 2004, Rucktaschel et al., 2011).  
Unlike the import machinery which has been proposed to be ATP-independent, 
both export and the ubiquitination machineries require a source of energy. In this 
context, Pex1 and Pex6 which are members of the AAA-ATPases family and can 
hydrolyse the ATP providing energy to pull the receptor out of the membrane 
(Miyata and Fujiki, 2005, Platta et al., 2005). These two AAA-peroxins are 
associated partially with the peroxisomal membrane via an interaction with the 
integral peroxisomal membrane Pex15 in yeast or Pex26 in mammals 
(Birschmann et al., 2003, Matsumoto et al., 2003).                                                                                  
Generally, ubiquitination refers to the labelling of a selected protein with the 76 
amino acid ubiquitin in order for it to be degraded.  It has been demonstrated that 
Pex5 is mono- and polyubiqitinated. The mono-ubiquitination of Pex5 is 
facilitated by E2-enzyme Pex4 (Platta et al., 2007). In addition, it was found that 
Pex12 from the RING-complex is involved in the Pex5 mono-ubiquitination 
(Platta et al., 2009). In pexΔ mutants, (e.g. pex1, pex4, pex6 or pex15), Pex5 
is polyubiquitinated by two members of the RING- complex (Pex2 and Pex10) for 
proteasomal degradation (Williams et al., 2008, Platta et al., 2009).                        
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Figure 1.1:  Model for peroxisomsal matrix protein import in S.cerevisiae.  
The peroxisomal matrix protein import pathway can be divided into four steps: (1) 
Cargo recognition in the cytosol (2) Cargo- receptor docking (3) Translocation 
and disassembly of the receptor-cargo (4) Return of the receptor to the cytosol. 
Peroxisomal matrix proteins with either a PTS1 or a PTS2 are recognized by the 
soluble receptor Pex5 or Pex7 respectively. Pex7 also requires co-receptors Pex18 
and Pex21 in S.cerevisiae. The receptor-cargo then associates with the 
peroxisomal membrane via the docking complex (Pex13, Pex14 and Pex17). The 
PTS receptor cargo is translocated across the peroxisomal membrane via a not 
well understood mechanism. Following cargo release the PTS-receptors are 
recycled back to the cytosol. This process requires the AAA-ATPase activities 
(Pex1 and Pex6), along with Pex4 and its membrane anchor Pex22. Some 
organisms have specific adaptations to this model (adapted from Rucktäschel et 
al, 2011).                                                                                                                     
  
12 
 
  1.6 Peroxisomal membrane proteins  
Peroxisomal membrane proteins (PMPs) are similar to the matrix proteins that 
both are encoded in the nuclear genome and synthesized via free cytosolic 
polyribosomes (Lazarow and Fujiki, 1985). However, the first indications that the 
import machinery for peroxisomal membrane proteins and for peroxisomal matrix 
proteins are entirely different came in the late 1980s when immunofluorescence 
microscopy studies of cells from Zellweger patients indicated that the peroxisomal 
matrix proteins are absent from the peroxisomal structures which are referred to as 
“ghosts” (Santos et al., 1988). Thus, two different mechanisms for sorting the 
peroxisomal membrane and matrix proteins have been considered.                          
                                                                
 
Out of the 32 known peroxins, Pex3, Pex19 and Pex16 can be classified as crucial 
peroxins for peroxisomal membrane biogenesis. In S. cerevisiae, Pex3 and Pex19 
have been identified as fundamental components for peroxisome formation (Gotte 
et al., 1998, Hettema et al., 2000). Furthermore, it has been shown that among 16 
different  (pex) mutants in S. cerevisiae, there were only two mutants,  pex3 and 
pex19, that resulted in a complete absence of peroxisomal membrane structures 
and mislocalisation of the PMPs into the cytosol where they break down rapidly 
(Hettema et al., 2000). In mammals, Pex16 is considered as an essential peroxin 
for peroxisomal membrane assembly (Honsho et al., 1998). Although Pex16 has 
been suggested to play an important role in peroxisomal biogenesis, this role 
seems to be species-specific because in some organisms lacking a functional copy 
of Pex16 such as Yarrowia lipolytica peroxisomal structure was observed (Eitzen 
et al., 1997).                                                                                                       
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1.7 Targeting of peroxisomal membrane proteins 
Peroxisomal membrane proteins can be targeted to the peroxisomes via two 
separate pathways. Proteins in the first category are synthesised in the cytosol and 
imported subsequently into the peroxisomal membrane post-translationally. These 
insertions of the PMPs depend on a peroxisomal membrane protein targeting 
sequences (mPTS).  The other group of the PMPs is targeted to the peroxisome 
via an uncharacterized area of  the ER (Platta and Erdmann, 2007a).                                                                                                                                           
 
The PMPs require a peroxisomal targeting sequence (mPTS) for correct targeting 
to the peroxisome. This mPTS has been identified recently in several PMPs and 
comprises combinations of hydrophobic and basic amino acid residues which 
provide a binding platform for Pex19. Furthermore, in the case of peripheral 
membrane proteins these residues are followed by a protein binding site but, in the 
case of integral membrane proteins, by a single transmembrane domain 
(Rottensteiner et al., 2004, Girzalsky et al., 2006).                                                                                                                                             
 
In addition, the PMPs also require the peroxins Pex19, Pex3 and, in some 
organisms, Pex16 for their sorting pathway. Pex19 is a hydrophilic and acidic 
protein that is present predominantly in the cytosol but interacts partially with the 
peroxisomal membrane (Gotte et al., 1998, Sacksteder et al., 2000). Pex19 has 
been characterized as a multi-functional protein due to its ability to bind most 
peroxisomal membrane proteins and import newly synthesized PMPs into the 
peroxisome (Snyder et al., 2000, Sacksteder et al., 2000). Therefore, Pex19 can 
act as a chaperon and a cytosolic receptor for the PMPs (Jones et al., 2004).  Pex3 
has been identified as an  integral peroxisomal membrane protein and it has been 
shown to act as a docking factor for Pex19-PMP complexes (Matsuzono et al., 
2006). Pex16 also has a role in the PMPs’ sorting pathway by acting as a receptor 
for Pex3-Pex19 complexes and it thus facilitates the targeting of the PMPs into 
the mature peroxisomes (Schliebs and Kunau, 2004, Matsuzaki and Fujiki, 2008).                                                                                                                                 
Only a few PMPs are imported into peroxisomes without assistance from Pex19, 
Pex3 and Pex16. These are directed to the ER before being imported into the 
peroxisome. Pex3 and Pex16 are the well known peroxins that are believed to 
follow an ER to peroxisome sorting pathway. However, the mechanism by which 
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these PMPs are inserted into the ER remains be identified.                                                                                         
                                                                                                           
1.8 The mevalonate pathway of isoprenoid 
The mevalonate pathway  (MVA) of isoprenoid biosynthesis has been studied 
extensively for a long time (Goldstein and Brown, 1990). This pathway exists in 
all mammals, higher plants, archaebacteria, algae (except chlorophytes) and in 
some protozoa (Trypanosome and Leishmania). Spurgeon and Proter (1981) have 
pointed out that Conrad Bloch (1958) and Feodor Lynen (1958) first described the 
mevalonate pathway in animals and yeast cells. In eukaryotic cells, the seven 
enzymes of the MVA pathway play a vital role in providing precursors that are 
essential for numerous cellular processes. For example, farnesyl diphosphate 
(FDP) mainly serves as a precursor for sterol biosynthesis but it is also used for 
protein prenylation (covalent attachment of a hydrophobic farnesyl or 
geranylgeranyl group to the C-terminus of some proteins) (Goldstein and Brown, 
1990). In addition, isopentenyl diphosphate is a precursor of the side-chain of 
ubiquinone (an electron carrier which is essential for the mitochondrial respiratory 
chain). Furthermore, the mevalonate pathway also supplies precursors for the 
side-chain of haem A; the synthesis of dolichol (an isoprenoid lipid which is 
involved in glycoprotein synthesis) and for tRNA prenylation. In plants, the MVA 
pathway provides FDP as a precursor for the synthesis of sesquiterpenes and 
triterpenes (Bouvier et al., 2005, Sapir-Mir et al., 2008).   
The five carbon isoprenoids isopentenyl diphosphate (IDP) and its allylic isomer 
dimethylallyl diphosphate (DMAPP) were, for several decades, considered to be 
synthesised only by the reactions of the mevalonate pathway (McGarvey and 
Croteau, 1995). Several decades, the mevalonate pathway was considered to be 
the only source of the IDP and DMAPP. However, it has been shown that the 
biosynthesis of IDP and DMAPP occurs via two pathways in higher plants: the 
non-mevalonate methylerythritl phosphate pathway (MEP) and the mevalonate 
pathway (MVA) (Lichtenthaler, 1999). The subcelluar location of the MEP 
pathway enzymes has been found to be entirely within the plastids (Hsieh et al., 
2008) whereas the subcellular distribution of the MVA pathway enzymes remains 
to be elucidated. 
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The mevalonate pathway is started with two molecules of acetyl CoA which are 
converted into acetoacetyl CoA by a thiolase (Figure 1.2). The second reaction 
catalysed by HMG-CoA synthase produces 3-hydroxy-3-methylglutaryl-CoA 
(HMG-CoA) from the condensation of acetyl-CoA with acetoacetyl-CoA. HMG-
CoA reductase, the rate-limiting enzyme of the mevalonate pathway, then 
catalyzes the conversion of HMG-CoA to mevalonate (MVA). Subsequently, the 
MVA is phosphorylated to form mevalonic acid-5- diphosphomevalonate by 
mevalonate and phosphomevalonate kinases. Next, the diphosphate is 
decarboxylated by diphosphomevalonate decarboxylase to produce isopentenyl 
diphosphate (IDP). The IDP is then converted to dimethylallyl diphosphate 
(DMAPP) by IDP-isomerase. IDP and DMAPP serve as substrates for farnesyl 
diphosphate synthase (FDP-synthase) to form geranyl diphosphate. The latter is 
then converted into the final product of the mevalonate pathway, farnesyl 
diphosphate, by FDP-synthase.  
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Figure 1.2: The mevalonate pathway of isoprenoid biosynthesis 
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1.9 The subcellular distribution of the mevalonate pathway enzymes among 
different organisms 
Although the reactions on the mevalonate pathway are well known, the 
subcellular distribution of the pathway enzymes is still a matter of debate. In 
mammals, the subcellular location of the MVA pathway enzymes was, for a long 
time, considered to be in the cytosol. However, this view changed in 1994 as a 
result of  an electron microscopy study to determine the subcelluar location of two 
enzymes of the mevlaonate pathway, mevalonate kinase and farnesyl diphosphate 
synthase , which were both found to be peroxisomal (Biardi et al., 1994, Krisans 
et al., 1994).                                               
Furthermore, the observation that the activity of the MVA pathway enzymes 
decreased  in tissue from Zellweger’s syndrome patients, a peroxisomal-
deficiency disease, also suggested that the mevalonate pathway might operate in 
the peroxisomes  (Krisans et al., 1994). Later on, a peroxisomal location was 
reported for most of the other pathway enzymes. For example, acetoacetyl-CoA 
thiolase was identified as a peroxisomal enzyme in mammals (Olivier et al., 
2000). In addaition, immunofluorrescence studies demonstrated that 
overexpressing hamster IDP-isomerase tagged with a hemagglutinin epitope was 
directed to the peroxisomes (Paton et al., 1997).  A GFP fusion protein of human 
phosphomevalonate kinase was also reported as a peroxisomal enzyme (Kovacs et 
al., 2007). Nevertheless, HMG-CoA reductase was an exception and found to be 
associated with the endoplasmic reticulum (Goldfarb, 1972, Liscum et al., 1985).                                                                                                    
By contrast, contradictory results have been reported that cast doubt on the 
peroxisomal location for mevalonate kinase; phosphomevalonate kinase and 
diphosphomevalonate decarboxylase in mammals (Gupta et al., 1999, Wanders 
and Waterham, 2006, Hogenboom et al., 2004b, Hogenboom et al., 2004c, 
Hogenboom et al., 2004a, Michihara et al., 2001). Thus, the subcellular location 
of the MVA pathway enzymes remains unclear.                                                                                                                        
In plants, investigation the subcellular location of the mevalonate pathway 
enzymes has had less attention. However, it has been shown that some of the 
MVA pathway enzymes are localized to the peroxisomes (Table 1.2).  
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A bioinformatics approach has identified acetoacetyl-CoA thiolase as a 
peroxisomal enzyme (Reumann et al., 2007). In addition, HMG-CoA reductase 
has a dual localization and is in the endoplasmic reticulum and within 
uncharacterized spherical structures (Leivar et al., 2005). Phosphomevalonate 
kinase and diphosphomevalonate decarboxylase also were found in the 
peroxisomes (Simkin et al., 2011). Nevertheless, some debate regarding the 
subcellular distribution of the MVA pathway enzymes in plant persists. For 
example, the GFP-fusion protein of the short version of Arabidopsis IDP-
isomerase was considered to be a cytosolic enzyme (Nakamura et al., 2001, 
Okada et al., 2008). However, Sapir-Mir et al, (2008) found that an internal GFP 
fusion protein of Arabidopsis IDP-isomerase is localized to the peroxisomes.  
Overall, the results are so contradictory that some of them must be incorrect. It is 
difficult to know which we can believe. On some enzymes there is no PTS or, at 
best, a very weak PTS. Therefore, one could conclude that the subcellular location 
of the MVA pathway enzymes needs further investigation.  
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Table 1.2: Compartmentalization of the mevalonate pathway enzymes from 
different organsimes. Homo sapiens (Hs); Mus musculus (Mm); Rattus 
norvegicus (Rn); Arabidopsis thaliana (At).                                                                                                                                 
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1.10 The biosynthesis of sterols   
Sterols are fundamental membrane components of all eukaryotic cells because 
they regulate membrane fluidity and permeability. Sterols can also interact with 
proteins and lipid within the membrane (Darnet and Rahier, 2004).  In addition, 
sterol biosynthesis can supply the eukaryotic cells with various precursors that are 
important for many cellular and development processes (Clouse, 2002). For 
example, cholesterol is the major sterol in animals and serves as a precursor for 
the formation of many important compounds such as steroid hormones, bile acids 
and vitamin D (Nes, 2011). In plants, a mixture of sterols exists supplying plant 
growth and development (e.g. growth hormone brassinosteroids and 
triterpenoids). 
The biosynthesis of plant sterols is similar to the cholesterol biosynthetic pathway 
in that both have the isoprenoid farnesyl diphosphate as the precursor. The first 
step unique to biosynthesis of sterols is the formation of squalene from two 
molecules of farnesyl diphosphate. Squalene is then converted to squalene 
epoxide which is then folded to give a sterol - lanosterol in mammals and fungi 
but the lanosterol isomer, cycloartenol in vascular green plants. The chemical 
structure of lanosterol resembles that of cycloartenol except that the latter 
possesses an additional cyclopropane ring (Figure 1.3). Furthermore, it has been 
reported that mutated forms of cycloartenol synthase from Dictyostelium 
discoideum and Arabidopsis thaliana will  synthesis lansterol instead of 
cycloartenol (Segura et al., 2003).  
By contrast, the subsequent steps of sterol biosynthesis are different in plants from 
those in mammals and fungi. Cholesterol (mammals) or ergosterol (fungi) 
synthesis requires the removal of the two C-4 methyl groups from lanosterol and 
this occurs early in the biosynthetic pathway. In plants, conversion of cycloartenol 
to phytosterols also requires removal of   both C-4 methyl groups but, although 
the first methyl group is removed early in the pathway, the second group is not 
removed until many steps later (Figure 1.3). Furthermore, removal of both methyl 
groups at C-4 is essential for the sterol molecule to be functional in the plasma 
membrane. In D.discoideum the biosynthesis of dictysterol, the major sterol that is 
produced by growing amoebae, requires conversion of squalene into cycloartenol 
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(Nes et al., 1990). This implies that the pathway of sterol biosynthesis in 
D.discoideum is the same as that in plants.  
In general, the enzymes catalysing sterol biosynthesis from squalene are believed 
to be located in the endoplasmic reticulum (Nes, 2011). For example, squalene 
synthase, the first committed enzyme of the sterol biosynthesis, has been 
identified as an ER enzyme in various organisms (Stamellos et al., 1993, Busquets 
et al., 2008). However, in D.discoideum, sterol biosynthesis enzymes that catalyze 
the initial steps on the pathway have a putative PTS which implies that part of the 
sterol biosynthesis pathway may take place in the peroxsiomes. The intracellular 
locations of the sterol biosynthesis enzymes in D.discoideum will be discussed in 
more detail in Chapter 4.                                                                                                           
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Figure 1.3: The biosynthesis of sterols in animals, fungi and plants. Sterols are 
derived initially from mevalonate. In plants, squalene is cyclised to form 
cycloartenol while in animals and fungi lanosterol is produced. Production of the 
final products of sterol biosynthesis from mevalonate requires more than 30 
enzyme-catalysed reactions.  Multiple biosynthetic steps are indicated by broken 
arrows (adapted from Hartmann, 1998). 
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1.11 Dictyostelium discoideum cellular and genetic aspects 
In 1935, Dictyostelium discoideum was first discovered by Raper in North 
Carolina deciduous forests. The life cycle of D. discoideum consist of two 
separate phases. In the vegetative (growth) phase, the amoeba exists as motile 
unicellular amoebae using bacteria as a food source. The second phase, termed 
development, is entered when the food supply is depleted. In this phase D. 
discoideum can differentiate into a multicellular organism by forming aggregates 
which develop in several stages to produce a fruiting body consisting of a stalk 
and spores. Based upon that the term ‘social amoeba’ was proposed.  
D. discoideum amoebae are eukaryotic cells because they contain a nucleus, 
nucleolus, ER, mitochondria, peroxisomes, microtubules, osmoregulatory 
vacuoles, microfibrils and other vacuoles that are bounded by a plasma 
membrane.  
The free-living D. discoideum amoebae feed naturally on bacterial cells using a 
process termed phagocytosis. However, several mutations have been generated to 
enable the amoeba to grow in a semi-defined liquid medium without any source of 
bacteria (axenic culture) (Watts and Ashworth, 1970). The amoebae can take up 
nutrients from the liquid medium by macropinocytosis. Growing amoebae 
axenically facilitates performing biochemical experiments and imaging live cells.   
D. discoideum is a haploid genome consisting of 34 Mb and arranged within six 
chromosomes.  Most genes, expressed in both vegetative and the development 
phase, are present as a single copy in the genome. The genome of D. discoideum 
is rich in adenine and thymine nucleotides (77.57%) and has simple sequence 
repeats (SSRs) more than any other known sequenced genome (Eichinger et al., 
2005).    
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1.12 Aim of the project 
As we discussed before, the compartmentalization of the mevalonate pathway 
enzymes is still a matter of debate. Furthermore, in Dictyostelium discoideum the 
intracellular locations of the MVA pathway enzymes are unknown. Thus, the aim 
of this study was to characterize the intracellular locations of both the MVA 
pathway and the sterol biosynthesis pathway enzymes in D. discoideum. I used a 
fusion protein approach that allowed for monitoring the localisation of the 
enzymes in vivo. For those proteins that were predicted to be integral to the 
membrane we tested this by membrane association studies. 
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Chapter 2   
Materials and Methods 
 
2.1   Media, chemicals and enzymes                                                                       
Components for making HL5 medium for growth of  Dictyostelium discoideum 
bacteriological peptone LP 0037, yeast extract LP 0021 were supplied by Oxoid. 
Escherichia coli and yeast growth media components were supplied by Difco 
Supplies.                                                                                                                      
All buffers for PCR and DNA polymerases were obtained from Bioline. New 
England Biolabs supplied restriction enzymes and buffers. Qiagen supplied the 
Miniprep Kit, the Gel Extraction Kit and the QIAamp DNA Mini Kit.                     
Unless otherwise stated in the Method section, all other chemicals and buffers 
were obtained from either BDH, Fisher or Sigma-Aldrich (UK).                              
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2.2  Strains and plasmids 
2.2.1  Strains  
Table 2.1: Dictyostelium discoideum, Escherichia coli and Saccharomyces cerevisiae 
strains.                                                                                                       
Source Use Genotype Strain 
Dictyostelium discoideum strains 
(Watts and 
Ashworth, 1970) 
Expression of fusion proteins 
and source of genomic DNA 
 Dictyostelium 
discoideum Ax-
2 strain 
Escherichia coli strains 
(Hanahan, 1983) Cloning constructs and 
recovery of plasmid DNA 
from Saccharomyces 
cerevisiae   
supE44lacU19
6 ((80 lacZ 
(80M15) 
hsdR17 recA1 
endA1 gyrA96 
thi-1 relA1 
Electroporation 
competent 
DH5α   
 
(Hanahan, 1983) Cloning constructs and 
expression of plasmid DNA   
supE44lacU19
6 ((80 lacZ 
(80M15) 
hsdR17 recA1 
endA1 gyrA96 
thi-1 relA1 
Chemically 
competent  
DH5α 
Saccharomyces cerevisiae strains 
EUROSCARF,  
Johann Wolfgang 
Goethe-University, 
Frankfurt, Germany 
Cloning constructs and 
source of genomic DNA. 
Mat a; his31, 
leu20, lys20, 
ura30  
Saccharomyces 
cerevisiae  
BY4742 
 EUROSCARF   Yeast complementation 
assay 
BY4741;Mat 
a;his3Δ1;leu2Δ0
;met15Δ0;ura3Δ
0;YML008::kan
MX4 
Saccharomyces 
cerevisiae  
erg6 mutant 
strain 
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2.2.2  Plasmids 
Table 2.2: Plasmids used in this study 
Source Lab 
reference 
Parental plasmid Promot
er 
Description 
This study pMA01 pMAA-1 A15P HMG-CoA synthase 
(isozyme A) - GFP 
This study pMA02 pDXA3C-MA A15P GFP- HMG-CoA synthase 
(isozyme B) 
This study pMA03 pMAA-1 A15P HMG-CoA reductase 
(isozyme 1) - GFP 
This study pMA04 pMAA-1 A15P HMG-CoA reductase 
(isozyme 2)- GFP 
This study pMA05 pGFP A15P Mevalonate kinase-GFP 
This study pMA06 pDXA3C-MA A15P  GFP-Mevalonate kinase 
This study pMA07 pDXA3C-MA A15P GFP-phosphomevalonate 
kinase 
This study pMA08 pDXA3C-MA A15P GFP-PTS1 (PKL) 
This study pMA09 pDXA3C-MA A15P GFP- phosphomevalonate 
kinase ( PKL) 
This study pMA10 pDXA3C-MA A15P GFP- phosphomevalonate 
decarboxylase 
This study pMA11 pGFP A15P Phosphomevalonate 
decarboxylase-GFP 
This study pMA12 pDXA3C-MA A15P GFP-IDP isomerase 
This study pMA13 pGFP A15P IDP isomerase-GFP 
This study pMA14 pDXA3C A15P IDP isomerase internal 
GFP 
Nuttall et 
al.,(2012) 
pmRFP p339-3mRFPmars A15P mRFP- PTS1 (HRY) 
This study pMA15 p339-3MA A15P mRFP-squalene synthase 
This study pMA16 pDXA3C-MA A15P GFP-squalene synthase 
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This study pMA17 pGFP A15P Squalene epoxidase-GFP 
This study pMA18 p339-3MA A15P mRFP-oxidosqualene 
cyclase 
This study pMA19 pMAA-2 A15P GFP- oxidosqualene 
cyclase 
This study pMA20 pDXA3C-MA A15P GFP- cycloartenol-C-24-
methyltransferase 
This study pMA21 pEH012 TPI Cycloartenol-C-24-
methyltransferase-GFP-
SKL 
This study pMA22 pEH116 TPI1 Cycloartenol-C-24-
methyltransferase ( 
PTS1) 
Lab stock pAS63 pEW319 His HcRed-SKL 
This study pMA23 pGFP A15P Methylsterol 
monooxygenase (isozyme 
1) -GFP 
This study pMA24 pGFP A15P Methylsterol 
monooxygenase (isozyme 
2) -GFP 
Nuttall et 
al, (2012) 
pGFP pDXA3C A15P GFP-PTS1 
Nuttall et 
al, (2012) 
pmRFP-PTS1 p339-3mRFPmars A15P mRFP-PTS1 
This study pMA25 P339-MA A15P DdPDI-mRFP 
This study pMA26 p339-3mRFPmars A15P DdCalnexin-mRFP 
This study pMA27 pDXA3C-MA A15 GFP-DdSQS-ΔPTS1 
This study pMA28 pMAA-2 A15 GFP-DdOSC-ΔPTS1 
This study pMA29 pDXA3C-MA A15 GFP-DdSMT-ΔPTS1 
This study pMA30 P339-MA A15 DdTop2-isomerase-mRFP 
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2.2.3  Plasmid design 
 
 2.2.4  Dictyostelium discoideum plasmids 
 
All Dictyostelium discoideum plasmids were based on the parental plasmids 
pDXA3C (Manstein et al., 1995) and p339-3mRFPmars (Fischer et al., 2004). 
pDXA3C-MA was generated by amplifying the open reading frame (ORF) for 
GFP by PCR (section 2.8.5) using pGFP as a template and VIP 1265 + VIP 1266  
as primers (Table 2.3). After digestion with HindIII and BamHI the fragment 
encoding GFP was ligated into pDXA3C that had also been digested with HindIII 
and BamHI as indicated below:  
 
 
 
Oligonucleotides VIP1890 and VIP 1891 (Table 2.3) were annealed and ligated 
into BamHI-XbaI  digested pDXA3C-MA to generate pMAA-2. The 
oligonucleotides encode an Ala-Gly-Ala-Gly linker sequence plus the restriction 
sites (Rs) for BamHI, XhoI, KpnI, NsiI, EcoRI, SacI, XbaI. This destroyed the 
original BamHI site. 
  
 
 
Similarly, oligonucleotides VIP 1405 and VIP 1406 (Table 2.3), consisting of 
restriction sites (Rs) for XhoI, EcoRI, NsiI, KpnI, BamHI and SacI, were annealed 
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and ligated into pGFP (Nuttall et al., 2012) that had been digested with HindIII 
and BamHI. Again, the original BamHI site was destroyed. The resulting plasmid 
was named pMAA-1. 
 
 
p339-3MA was generated by annealing and inserting the oligonucleotides VIP 
1046 and VIP 1047 (Table 2.3) into BamHI- ClaI digested p339-3mRFPmars. The 
oligonucleotides encode the amino acid linker sequence Gly-Ser-Gly-Ala and 
restriction sites (Rs) BamHI, XbaI, SaII, PstI, SphI, EcoRI as shown below: 
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2.2.5  Plasmid design for homologous recombination in S. cerevisiae   
pMA22 encoding  cycloartenol-C-24-methyltransferase ( PTS1) was generated 
by homologous recombination in yeast. First, plasmid pEH116 was linearised 
with SacI and PstI. The open reading frame (ORF) of D. discoideum cycloartenol-
C-24-methyltransferase  PTS1 (DdSMT  PTS1) was then amplified by PCR 
using primers VIP 1590, VIP 1591 (Table 2.3) and the DNA template pMA20. 
The 5`end of the product was complementary to the final 18 nucleotides at the  
SacI – digested end of plasmid pEH116 (Figure 2.1). Similarly, the 3`end of the 
PCR product was complementary to the 18 nucleotides at the PstI digested end of 
the plasmid. When S. cerevisiae (BY4742) was transformed with the PCR product 
and the linearised pEH116, the gapped plasmid was repaired by homologous 
recombination. Plasmid pMA21encoding Dd SMT-GFP-PTS1 was obtained 
similarly. Initially, primers VIP 049 and VIP 272 (Table 2.3) were used in 
amplification of Dd SMT from pMA22. The plasmid pEH012 was digested with 
SacI and BamHI and the PCR product was inserted into the linearised pEH012 by 
homologous recombination.  
 
 
 
 
 
A) PCR reaction used to amplify the ORF of DdSMT from pMA20  
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B) Homologous recombination between DdSMT(ΔPTS1) and linearised pEH116  
 
 
 
C) The recombinant vector (pMA22) encoding the DdSMT(ΔPTS1) 
 
Figure  0.1: Generating the pMA22 construct using homologous 
recombination. 
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2. 3 Primers 
 
Table 2.3: Primers used in this study 
 
Application Sequence (5’-3’) Name 
(F) primer to amplify  HMG-
CoA synthase (A)  
GACCTCGAGAAAAAATGACAAAA  
CCAGAAAATATCGG    
VIP 1958 
(R) primer to amplify HMG-
CoA synthase (A) 
GCAGGATCCAGCACCAGCACC  
TTTTTTTAAAATTGATAAAACTGA  
TTTAG 
VIP 1959 
(F)  primer to amplify HMG-
CoA synthase (B) 
GACGGATCCAGCACCAGCACC  
ATGAAAAAAACAAAAGATATT  GGA 
VIP 1960  
(R) primer to amplify HMG-
CoA synthase (B) 
GCATCTAGATTACAATTTTGAAGA  
TATAATTGGCT 
VIP 1961  
(F) primer to amplify HMG-
CoA reductase (A) 
GACCTCGAGAAAAAATGCTATTC  
GCTCCACCAAATTTAGAAACT  
AAAGAGTTATTTTGGATTATATAT  
ATTTTAATCCTTATACCAAAAGTA  
TTCGC 
VIP  1753 
 
(R) primer to amplify HMG-
CoA reductase (A) 
GCAGGATCCAGCACCAGCACC  
ATTTGTTTTTGCTCTATTATATTG  AAG 
VIP 1408  
(F) primer to amplify HMG-
CoA reductase (B) 
GACCTCGAGAAAAAATGATTAGA  
ATTGGTTCAAATTTA 
VIP 1409 
(R) primer to amplify HMG-
CoA reductase (B) 
GCAGGATCCAGCACCAGCACC  
ATCAGAATGTGGTAAATTATGAG    
VIP 1410 
(F)  primer to amplify 
mevalonate kinase, to clone it 
at the N-terminus of GFP 
GACAAGCTTAAAAAATGATATCA  
AACCAAGACAATATC 
VIP  1269  
(R) primer to amplify 
mevalonate kinase, to clone it 
at the N-terminus of GFP 
GCAGGATCCAGCACCAGCACC  
TTTTTGAATTGGTAAAATATTAATAG       
VIP  1270 
(F) primer to amplify 
mevalonate kinase, to clone it 
downstream of the GFP 
GACGGATCCAGCACCAGCACCATG  
ATATCAAACCAAGACAATATC   
VIP 1361 
(R) primer to amplify 
mevalonate  kinase, to clone 
GCATCTAGATTATTTTTGAATTGGTAA  VIP 1362 
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it downstream of the GFP AATATTAATAG  
(F)  primer to amplify 
phosphomevalonate kinase 
GACGGATCCAGCACCAGCACCATG  
GAAAGAGTTGTTTGTTCAGC 
VIP 1267   
(R) primer to amplify 
phosphomevalonate kinase 
GCATCTAGATTATAATTTTGGAGT  
AATATGAGA   
VIP 1268 
(R) primer to amplify 
phosphomevalonate kinase Δ 
PTS1(-PKL) 
GCATCTAGATTAGGAGTAATATGA  
GACATATCAATTG   
VIP 1369 
(F)  primer to amplify 
phosphomevalonate 
decarboxylase, to clone it at 
the N-terminus of GFP 
GACAAGCTTAAAAAATGGTTTTA  
GCATCAGTTACATG 
VIP 1253 
(R) primer to amplify 
phosphomevalonate 
decarboxylase, to clone it at 
the N-terminus of GFP 
GCAGGATCCAGCACCAGCACCATT  
TAATTGTTTTGGTAAACCAGTTG 
VIP 1254 
 
(F)  primer to amplify 
phosphomevalonate 
decarboxylase, to clone it  
downstream of the GFP 
GACGGATCCAGCACCAGCACCATG  
GTTTTAGCATCAGTTACATG 
VIP 1323 
 
(R) primer to amplify 
phosphomevalonate 
decarboxylase, to clone it 
downstream of the GFP 
GCATCTAGATTAATTTAATTGTTT  
TGGTAAACCAG 
VIP 1324 
 
(F)  primer to amplify IDP-
isomerase, to clone it at the 
N-terminus of GFP 
GACAAGCTTAAAAAATGGCAACAAAA  
TCAAATGAAGAG 
VIP 1328 
 
(R) primer to amplify IDP-
isomerase, to clone it at the 
N-terminus of GFP 
GCAGGATCCAGCACCAGCACCATA  
TCTATGAATTGTATTTGTTGG 
VIP 1329 
(F)  primer to amplify IDP-
isomerase, to clone it 
downstream of the GFP 
GACGGATCCAGCACCAGCACCATG  
GCAACAAAATCAAATGAAGAG 
VIP 1288  
 
(R) primer to amplify IDP-
isomerase, to clone it 
downstream of the GFP 
GCATCTAGATTAATATCTATGAATTGT  
ATTTGTTGG 
VIP 1289  
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(F)  primer to generate 
internal GFP-fusion protein 
of the IDP-isomerase  
GACAAGCTTAAAAAATGGCAACAAAA  
TCAAATGAAGAG 
VIP 1418 
(R) primer to generate 
internal GFP-fusion protein 
of the IDP-isomerase 
GCAGGTACCAGCACCAGCACCATA  
TCTATGAATTGTATTTGTTGG 
VIP 1419   
 
(F)  primer to amplify GFP  GACGAGCTCATGAGTAAAGGAGAA 
GAACTTTTC 
VIP 1420 
(R)  primer to amplify GFP GCACTCGAGTTTGTATAGTTCATCCAT  
GCC 
VIP 1421 
(F)  primer to amplify 
squalene synthase, to 
generate mRFP fusion protein  
GGTGCTGGATCCATGCAATATATG 
AAATCACTTGCT C 
VIP 1200 
(R) primer to amplify 
squalene synthase, to 
generate mRFP fusion protein 
GCTAATCGAT TTATAATTTCGAAAA 
AAAGTT TGGACC 
VIP 1201 
(F)  primer to amplify 
squalene synthase, to clone it  
downstream of the GFP 
GACGGATCCAGCACCAGCACCATG  
CAATATATGAAATCACTTGCTC 
VIP 1892 
 
(R) primer to amplify 
squalene synthase, to clone it 
downstream of the GFP 
GCATCTAGATTATAATTTCGAAAA  
AAAGTTTGGACC 
VIP 1893 
 
(R) primer to amplify 
squalene synthase ΔPTS1 
GCATCTAGATTAAAAAAAGTTTGG  
ACCATGACG 
VIP 2184 
(F)  primer to amplify 
squalene  epoxidase 
GACAAGCTTAAAAAATGGAAGATATT  
CAATTTGAAAATG 
VIP 1309 
(R) primer to amplify 
squalene  epoxidase 
GCAGGATCCAGCACCAGCACCTTT  
TGTTAATCTTAAAATAATACA    
VIP 1310 
 
(F)  primer to amplify 
oxidosqualene cyclase 
GGTGCTGGATCCATGACAACTACT  
AATTGGAGT    
VIP 1377 
(R) primer to amplify 
oxidosqualene cyclase 
GCTAGAATTCTTAAATTTTAGATTT  
TAAATATAATTG 
VIP 1378 
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(F) primer to amplify 
oxidosqualene cyclase ΔPTS1 
GACGGATCCATGACAACTACTAAT  
TGGAGT     
VIP 2105 
(R) primer to amplify 
oxidosqualene cyclase ΔPTS1 
GCAGAATTCTTATTTTAAATATAA  
TTGATTATATCTAG 
VIP 2185 
(F)  primer to amplify 
Cycloartenol-C-24-
methyltransferase 
GACGGATCCAGCACCAGCACCATG  
GTATTAATTCAAACTAATCATC 
VIP 1453 
(R) primer to amplify 
Cycloartenol-C-24-
methyltransferase 
GCATCTAGATTAAAGTTTAGCAGC  
ATTTGG    
VIP 1454 
 
(R) primer to amplify 
Cycloartenol-C-24-
methyltransferase ΔPTS1 
GCATCTAGATTAAGCATTTGGTTT  
TGAAGATAAGAATC 
VIP 2186 
(F)  primer to clone 
Cycloartenol-C-24-
methyltransferase into a yeast 
vector 
AAAAACACATACATAAACGAGCTC  
AAAATGGTATTAATTCAAACTAAT  
CATC   
VIP 1590 
 
(R) primer to amplify 
Cycloartenol-C-24-
methyltransferase, to clone it 
into a yeast vector 
TGCACCCGCCCCTGCTCCCTGCAG  
AGCATTTGGTTTTGAAGATAAG    
VIP 1591 
 
(F)  primer to amplify 
Cycloartenol-C-24-
methyltransferase, to clone it 
into a yeast vector  
GTTTTCCCAGTCACGACG VIP 049 
(R) primer to amplify 
Cycloartenol-C-24-
methyltransferase, to clone it  
into a yeast vector  
CCCATTAACATCACCATC   
 
VIP 272 
(F)  primer to amplify 
Methylsterol monooxygenase 
(1) 
GACAAGCTTAAAAAATGGAATCACTT  
TCATTAAAATTTATTG 
VIP 1461 
(R) primer to amplify 
Methylsterol monooxygenase 
(1) 
GCAGGATCCAGCACCAGCACCTTC  
AGATTTATTAATTGATTTTTTTTC 
VIP 1462 
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(R) primer to amplify 
Methylsterol monooxygenase 
(Wada et al.) 
GCAGGATCCAGCACCAGCACCTTC  
AGATTTACCAGCAGCAAG    
VIP 1808 
 
(F)  primer to amplify 
Calnexin  
GACAAGCTTATGAATAAATTAATT  
TTATTATTAATTTTATC   
VIP 1749 
 
(R) primer to amplify 
Calnexin 
GCAGGATCCAGCACCAGCACCTTT  
AACTTTATTAGTTCTTTTTGTAAC 
VIP 1750 
 
(F)  primer to amplify PDI GACAAGCTTATGAAAATATTATTATTT  
GTTACATTA 
VIP 1575 
 
(R) primer to amplify PDI GCAGGATCCAGCACCAGCACCTTT  
TGATTTGAAAGATTCTAAAATATTG   
VIP 1576 
 
(F) primer to amplify GFP  GACAAGCTTAAAAAATGAGTAAAGGA  
GAAGAACTTTTC 
VIP 1265 
(R) primer to amplify GFP  GCAGGATCCTTTGTATAGTTCATCCAT  
GCC 
VIP 1266 
Oligonucleotides used to 
generate pMAA-2 
GATCTGCTGGTGCTGGTGGATCCCTC  
GAGGGTACCATGCATGAATTCGAG  
CTCT 
VIP 1890 
Oligonucleotides used to 
generate pMAA-2 
ACGACCACGACCACCTAGGGAGCTC  
CCATGGTACGTACTTAAGCTCGAG  
AGATC 
VIP 1891 
 
Oligonucleotides used to 
generate pMAA-1 
AGCTTCTCGAGGAATTCATGCAT  
GGTACCGGATCCGAGCTCA 
VIP 1405 
Oligonucleotides used to 
generate pMAA-1 
AGAGCTCCTTAAGTACGTACCATGG  
CCTAGGCTCGAGTCTAG 
VIP 1406 
Oligonucleotides used to 
generate pMA08 
GATCCGTTGCAATTGATATGTCTCAT  
ATTACTCCAAAATTATAAT 
VIP 1372 
Oligonucleotides used to 
generate pMA08 
GCAACGTTAACTATACAGAGTATAA  
TGAGGTTTTAATATTAGATC 
VIP 1373 
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Oligonucleotides encoding 
the 12 amino acids at the C-
terminus of IDP-isomerase 
TCGAGCCATTAGTTGAACCAACAAAT  
ACAATTCATAGATATTAAT 
VIP 1447 
Oligonucleotides encoding 
the 12 amino acids at the C-
terminus of IDP-isomerase 
CGGTAATCAACTTGGTTGT 
TTATGTTAA  GTATCTATAATTAGATC 
VIP 1448 
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2.4 Cell Culture 
 
Table 2.4: Culture media 
 
Culture media Description 
 
Bacterial medium ( 2TY) 
 
1.6% Bacto tryptone, 1% yeast extract, 0.5% NaCl 
HL5 glucose medium for 
growing D. discoideum 
amoebae 
1.43 %  bacteriological peptone, 0.715%  yeast 
extract, 1.54 %  D-glucose, 0.128 % Na2HPO4 
12H2O, 0.0486 % KH2PO4  
Yeast medium (YPD) 1% peptone, 1% yeast extract, 2% glucose 
 
Yeast minimal medium 2 
(ym2) 
 
 
0.17% yeast nitrogen base (without amino acids and 
ammonium sulphate), 0.17% ammonium sulphate, 
1% casaminoacids, 2% glucose or galactose as 
required. Leucine and tryptophan were added from 
stocks to the autoclaved media, as required. 
All the above media were dissolved in distilled water and sterilised by autoclaving 
at121°C for 15-20 minutes. If required, antibiotics were added to appropriate 
concentrations after the media had been autoclaved and cooled to ~ 50 (Table 2.5).  
For preparation of solid medium, 2% Bacto-agar was added to the liquid medium 
which was then autoclaved. After cooling (~50°C) and addition of the any antibiotics, 
the autoclaved medium was poured into sterile Petri dishes and allowed to solidify at 
room temperature. The plates were then stored at 4 ˚C. 
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Table 2.5: Antibiotics used in this study 
 
Antibiotics 
 
Final concentrations 
 
Ampicillin 
 
75 g/ml 
 
G418 
 
10 g/ml 
 
Blasticidin 
 
10 g/ml 
 
Cycloheximide 
 
0.05 μg/ml 
 
BMS181221 
 
4.3μM 
  
 
 
2.5 Growth of Escherichia coli 
 2.5.1 Growth and maintenance of E. coli 
E.coli  was  obtained  from a frozen stock (-80°C ) and streaked  on a 2TY agar 
plate for overnight growth  at 37°C. Transformed strains that were ampicillin 
resistant grown on 2TY selective medium. Each plate was kept at 4°C for use for 
up to a week.  For long-term storage, E.coli was grown overnight at 37°C in 2TY 
medium with shaking at 180 rpm. The following day, 0.8 ml culture was mixed 
with 0.8 ml autoclaved 30% (v/v) glycerol in a 1.8ml cryotube (Nunc) and placed 
in the -80°C.                                                                                                    
 
  2.5.2  Preparing  chemical-competent cells of E.coli DH5α 
 Routinely, the preparation of the chemical competent cells was carried out at 0ºC. 
E.coli DH5α was streaked on a 2TY plate and incubated at 37ºC overnight. 5   ml 
2TY medium was inoculated with a single colony of DH5α and incubated at 37 ºC 
in a shaking incubator (~ 200 rpm) overnight. Next moring, the cells were diluted 
into 200ml 2TY to OD = 0.05 at 600nm and incubated at 30 ºC. Once the culture 
had reached the mid-log phase (OD = 0.5-0.6 at 600nm), the cells were incubated 
at 0 ºC for 15 minutes. Subsequently, the cells were harvested in pre-cooled 50ml 
Falcon tube by centrifugation at 3000 rpm for 10 minutes at 4 ºC in the 4×4 place 
rotor of a Sigma 4-16 K centrifuge. The supernatant was removed and the pellet 
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was resuspended in 70ml ice-cold RF1 (100mM rubidium chloride, 50mM 
manganese chloride, 30mM potassium acetate, 10mM calcium chloride, 15% (v/v) 
glycerol adjusted to pH 5.8 with 2M acetic acid).The cells were incubated at 0 ºC 
for 15-30 minutes and then centrifuged at 3000 rpm for 10 minutes at 4 ºC. The 
supernatant was removed before the pellet was resuspended in 16ml RF2 (10mM 
MOPS, 10mM rubidium chloride, 75mM calcium chloride, 15% (v/v) glycerol 
adjusted to pH 6.8 with NaOH) at 0˚C. The suspension of bacteria was then 
dispensed as aliquots of 200µl or 400µl into 1.5ml pre-cooled Eppendorf tubes 
and immediately frozen in liquid nitrogen. The bacteria were stored at -80 ºC.       
                                                                                                    
2.5.3  Transformation of chemical-competent E.coli by the heat-shock 
method                                                                                                                        
A 100µl aliquot of chemical competent E.coli (DH5α) for each transformation 
was placed on ice to thaw. 1µl plasmid DNA (1-2µg DNA) or 10µl ligation 
reaction was added to the bacteria and then mixed gently before being placed on 
ice for 30 minutes. The bacteria were heat-shocked in a 42°C water bath for 90 
seconds and immediately placed on ice for 1-2 minutes.  400 µl 2TY medium 
were added to each sample before being incubated for one hour at 37°C.   The 
sample was centrifuged in a micro-centrifuge for 30 seconds at 13,000 rpm. 800 
µl of the supernatant was removed and the pellet was resuspended in the residual 
medium.  The bacterial suspension was plated out on a 2TY agar plate with 
ampicillin and incubated at 37°C overnight.                                                               
2.5.4 Transformation of E.coli by electroporation  
10µl (10x dilution) of yeast genomic DNA (section 2.7.4) was added to a single 
40µl aliquot of thawed electrocompetent E.coli and mixed. The bacteria were 
incubated on ice for 1 minute and transferred to a pre-cooled 2mm electroporation 
cuvette (Cell Projects). A 5 msec pulse was applied at 2,5 kV, 201, 25F and 
the cells were mixed with 600 µl of 2TY medium before being transferred to a 
1.5ml Eppendorf tube. The bacteria were incubated at 37C for 30 minutes and 
then centrifuged in a micro-centrifuge for 5 minutes at 5,000 rpm. The pellet was 
re-suspended in 100l of the supernatant. The bacterial suspension was streaked 
on a 2TY ampicillin plate and incubated at 37C overnight.                                           
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2.6 Axenic growth of Dictyostelium discoideum  
 2.6.1 Growth and maintenance of D.discoideum 
Routinely, amoebae of D.discoideum strain Ax-2 were grown axenically in HL5 
glucose medium at 22C with shaking at 160 rpm (Watts and Ashworth, 1970). 
Stocks of amoebae were stored in a 22C incubator without shaking for a 
maximum of 2 weeks, before being sub-cultured into fresh HL5 glucose medium. 
For long-term storage, 10
8 
cells were harvested by centrifugation for 5 minutes at 
1000 rpm at 4C. The supernatant was removed and the pellet was resuspended in 
chilled horse serum (Sigma) containing 7.5% (v/v) DMSO and mixed thoroughly. 
The mixture was dispensed as 1ml samples into 1.8ml cryotubes (Nunc). The 
tubes were kept in a pre-cooled polystyrene container at -80C overnight, before 
being stored at -80C.                                                                                                  
2.6.2  Isolation of D. discoideum genomic DNA by using a QIAamp DNA Mini 
Kit                                                                                                                               
D. discoideum genomic DNA was isolated by using a QIAamp DNA Mini Kit. 
Amoebae were cultured in 70ml HL5 glucose medium at 22C with shaking at 
160 rpm for 3 days. 2×10
7 
amoebae were centrifuged for 5 minutes at 1000 rpm 
and the supernatant was removed. The pellet was resuspended in 10ml PBS buffer 
and subsequently centrifuged for 5 minutes at 1000 rpm. The supernatant was 
removed and 200 l PBS buffer were added and mixed thoroughly. 20 l 
protenase K was then added and mixed gently. Following steps were carried out 
according to the manufacturer’s instructions.                                                             
 2.6.3  Isolation of D. discoideum cDNA by using a QIAamp DNA Mini Kit 
 A QIAamp DNA Mini Kit was also used according to the manufacturer’s 
instructions  to isolate cDNA from a cDNA library (200l) constructed by 
Stratagene in λzap by use of mRNA prepared from D. discoideum strain Ax-2 
amoebae harvested during exponential axenically growth.                                             
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2.6.4  Transformation of D. discoideum by electroporation  
Great care was taken to keep the suspensions of amoebae sterile and as many 
steps as possible were carried out in a lamina flow cabinet.                                       
Transformation of amoebae by electroporation was performed according to the 
method of (Pang et al., 1999). 5×10
6
 amoebae were harvested by centrifugation in 
a sterile pre-cooled 15ml Falcon tube for 5 minutes at 1000rpm and at 4˚C. The 
supernatant was removed aseptically. 8 ml sterile ice-cold H50 medium (10mM 
NaCl, 5mM NaHCO3, 1mM MgSO4, 1mM NaH2PO4, 20mM HEPES, 50mM KCl, 
adjusted to pH 7.0 with KOH) were added to the cells and vortexed thoroughly. 
The cells were centrifuged and the supernatant was removed. The pellet was 
resuspended again in 8 ml H50 medium and centrifuged. Following 
centrifugation, the last residual supernatant was removed with a sterile pipette and 
the pellet was resuspended in 100μl H50 medium. 10 μl plasmid DNA were added 
and mixed gently. The mixture then was transferred to a chilled electoporation 
cuvette (1mm gap). Two pulses were applied at 0.65 kV and 25Ω (using a Bio-
Rad Gene Pulser) and the cuvette then was incubated on ice for 5 minutes. The 
cells then were transferred into a sterile Petri dish containing 10 ml HL5 glucose 
medium and incubated at 22 ˚C overnight. Next day, appropriate antibiotic was 
added to the cells before incubation at 22 ˚C for approximately 2 weeks.                 
  2.6.5  Fluorescence microscopy (D.discoideum)                                                    
Unfixed amoebae were analysed using a Zeiss Axiovert 200M microscope (Carl 
Zeiss Microimaging, Inc.) equipped with an Exfo X-cite 120 excitation light 
source, band pass filters (Carl Zeiss Microimaging, Inc. and Chroma Technology 
Corp.), an  plan-Fluar 100X/1.45 NA or a Neofluar 40 ×/1.3 NA (numerical 
aperture) oil Ph3 objective lens (Carl Zeiss MicroImaging, Inc.) and a digital CCD 
camera (Orca ER, Hamamatsu). Image acquisition was performed using Openlab 
software (Improvision). Live cells were imaged in 0.7% NaCl at room 
temperature.                                                                                                                 
Unless otherwise stated, fluorescence images were collected as 1 μm Z-stacks, 
merged into one plane after contrast enhancing in Velocity, and processed further 
in Photoshop (Adobe). Bright field images were collected in one plane and added 
into the blue channel in Photoshop (Adobe).   
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For each transformant many fields were examined under the microscope but 
essentially all cells had the same appearance. However, the fluorescence intensity 
varied. Probably this is because some cells contain more copies of the plasmid 
encoding the fluorescent protein than others. 
 2.7 Growth of Saccharomyces cerevisiae                                                              
  2.7.1   Growth and maintenance of S.cerevisiae 
The S.cerevisiae strains were plated out on a YPD plate containing 2% glucose 
and incubated at 30 
o
C for 2 days. Yeast was stored at room temperature for up to 
1 week. For long-term storage, the strains were cultured in 3ml liquid medium at 
30
 o
C with shaking at 180 rpm overnight. Next day, 0.8 ml of culture was mixed 
with 0.8 ml 30% glycerol in a 1.8ml cryotube (Nunc) and stored at -80°C.              
2.7.2  Yeast high efficiency transformation procedure                                          
The yeast high efficiency transformation protocol was based on the method of 
Gietz et al., 1992. Yeast were grown in 3 ml liquid medium at 30C overnight. 
The overnight culture was diluted to OD600=0.05-0.1 in 10 ml fresh culture 
medium for each required transformation and the cultures were grown to mid-log 
phase (OD600=0.5-0.6). The cells were harvested by centrifugation for 5 minutes 
at 5000 rpm, and the pellet was resuspended in sterile Millipore water. The cells 
were centrifuged again (5 minutes at 5000 rpm) and the supernatant was removed. 
The pellet then was resuspended in 1ml TE/LiAc buffer (10mM Tris-Cl pH 7.5, 
0.1 mM DTT, 0.1 M LiAc pH 7.5). The cells were centrifuged for 1 minute at 
9000 rpm, the supernatant was taken off and the pellet was resuspended in a 50 l 
TE/LiAc. 2 l plasmid (0.5g-1g), 5l single stranded DNA (`Salmon testes) 
and 300 l 40% PEG 4000 solution (50% PEG 4000, 10mM Tris-Cl pH 7.4, 
0.1mM EDTA pH 8.0, 0.1M LiAc pH 7.5) were added  to the samples and mixed 
thoroughly.  The cells were incubated at 30C for 30 minutes and heat-shocked in 
a 42°C water bath for 15 minutes. The cells were centrifuged for 1 minute at 7000 
rpm and the supernatant was removed. The pellet was resuspended in 100l TE 
(10mM Tris-Cl pH 7.5, 0.1 mM EDTA). The cells were streaked on a selective 
agar plate and incubated at 30 C for 2 days.                                                             
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2.7.3  Yeast one step transformation procedure  
The yeast one step transformation was performed according to Chen et al., 1992. 
S.cerevisiae strains were grown in 3ml YPD at 30 C overnight. 200l of the 
cultures were centrifuged in a micro-centrifuge for 1 minute at 13,000 rpm and the 
supernatant was removed. The pellet was resuspended in 2 μl (0.5 μg-1 μg) of the 
appropriate plasmid by vortexing. 5l (50g) single stranded DNA and 50l one-
step buffer (0.2M LiAc pH 5.0, 40% (w/v) PEG4000, 0.1M DTT) were added. 
The cells were incubated at room temperature for 3-4 hours with vortexing 
intermittently. The cells then were heat-shocked in a water bath at 42 C for 30 
minutes. They were then plated out on solid minimal medium and incubated at 30 
ºC for two days.                                                                                                           
 2.7.4   Isolation of yeast total DNA 
Yeast cells were grown in 6ml of appropriate culture medium (YPD or minimal 
medium) at 30 ºC overnight. The cells then were harvested by centrifugation in a 
2ml screw-cap tube for 1minute at 13,000 rpm and the supernatant was removed. 
The pellet was resuspended in 1ml sterile water and the cell suspension was 
centrifuged for 1 minute at 13,000rpm. The supernatant was removed. 200l 
TENTS (20mM Tris-HCl pH 8.0, 1mM EDTA, 100mM NaCl, 2% (v/v) Triton X-
100, 1% (w/v) SDS), 200l of 452-600m glass beads and 200l 
phenol:chloroform:isoamyl alcohol (25:24:1) were added to the pellet and mixed. 
A mini bead beater (Biospec Products) was used at full speed for 45 seconds to 
break open the cells and the mixture was subsequently centrifuged for 30 seconds 
at 12,000rpm. 200l of TENTS was added to the sample and vortexed thoroughly. 
The sample was centrifuged for 5 minutes at 12,000rpm and 350l of the 
supernatant were transferred into an Eppendrof tube. 200l phenol: chloroform: 
isoamyl alcohol was added to the sample which was vortexed thoroughly. The 
sample was centrifuged for 5 minutes at 12,000rpm and subsequently 200l of the 
supernatant were transferred into an Eppendrof tube. 15l 3M sodium acetate pH 
5.2 and 2.5x the volume of the sample of 100% ethanol were added to the sample 
and vortexed. The sample was incubated at -20 ºC for 2 hours or overnight. The 
sample was then centrifuged for 15 minutes at 12,000rpm and the supernatant was 
removed. The pellet was resuspended in 500l 70% ethanol and the suspension 
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centrifuged for 1 minute at 12,000rpm. The supernatant was removed and the 
pellet was resuspended in 200l TE pH 8.0 with 2l RNAse (10g/ml). The 
sample then was incubated at room temperature for 10 minutes. 20l 3M sodium 
acetate pH 5.2 and 2.5x the sample volume of 100% ethanol were added, before 
the sample was incubated at -20 ºC for 1 hour or overnight. The sample was 
centrifuged for 15 minutes at 12,000 rpm and the pellet was resuspended in 500l 
70% ethanol. The suspension was centrifuged for 1 minute at 12,000 rpm and the 
supernatant was removed. The sample was incubated at 30 ºC in order to 
evaporate the last trace of the ethanol. The pellet was resuspended in 50l TE pH 
7.5.                                                                          
2.7.5 Fluorescence microscopy (S.cerevisiae) 
Yeast cultures were grown to log phase and images captured on a Zeiss Axiovert 
200M microscope (described in 2.5.5).  Fluorescence images were routinely 
collected as 0.5 m Z-stacks.  
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2.8 Molecular cloning 
2.8.1  Preperation of  plasmid DNA 
A single colony of  transformed  E.coli  was inoculated into 5ml 2TY medium 
containing the appropriate selection antibiotic. The cells were grown at 37º C with 
shaking at ~ 200 rpm overnight. Next day, the plasmid DNA was purified using 
the QIAprep Spin Miniprep Kit (Qiagen), according to the manufacturer’s 
                             ).www.qiagen.comtocol was obtained from instructions (the pro 
2.8.2   Restriction enzyme digestion of plasmid DNA  
Plasmid DNA was digested by using appropriate restriction endonucleases (New 
England Biolabs).  Each reaction was carried out in a final volume of 20µl, 
consisting of plasmid DNA (0.5g-1g), 5 units restriction enzyme per 1g DNA, 
2 µl 10x compatible restriction buffer and the volume was made up to 20µl using 
sterile Millipore water. The mixture was incubated at 37ºC for 2 hours. For 
multiple restriction enzyme digestion when the restriction endonucleases shared 
the same buffer, the double digestion was set up with both enzymes. If the 
restriction endonucleases needed different buffers, the digestion reaction was 
carried out with one enzyme using its appropriate buffer. Subsequently, the first 
buffer was removed using a QIAquick Gel Extraction Kit (Qiagen) according to 
the manufacturer’s instructions and the second digestion reaction was set up using 
the compatible buffer.   
 
 2.8.3  DNA electorophoresis on agarose gels 
Agarose gel electrophoresis was used to analyse digested DNA fragments. A 1% 
agarose gel was prepared by adding Bio-Rad Ultra Pure DNA Grade agarose to 
the TBE buffer (0.04M Tris-acetate, 0.04M boric acid, 0.001M EDTA) and the 
mixture was heated in  a microwave until the agarose had melted. The mixture 
was cooled down to ~50 ˚C and ethidium bromide (0.5g/ml, final concentration) 
was added. Subsequently, the mixture was poured into a gel tray containing a 
comb and allowed to set at room temperature. The gel then was placed in the 
electrophoresis tank and covered with TBE buffer. The DNA was mixed with 6× 
loading dye (0.25% bromophenol blue, 0.25% xylene cyanol FF, 30% glycerol in 
distilled water) and loaded onto the gel. A DNA marker (Hyperladder I, Bioline 
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Ltd.) was run alongside the DNA sample in order to determine the size of DNA 
fragments. The electrophoresis gel was run at a constant voltage of ~ 100 V. The 
DNA fragments were analysed using an ultraviolet transilluminator imaging 
system (Gene Genius) and a photograph recorded digitally using Genesnap 
software (SynGene).                                                                                                    
 
2.8.4   DNA elution from agarose gels  
The required DNA fragment was extracted from the agarose gel by using a 
QIAquick Gel Extraction Kit, following the manufacturer’s instructions (the 
                                                        ).www.qiagen.comprotocol was obtained from  
 2.8.5   Amplification of DNA by the polymerase chain reaction (PCR) 
The polymerase chain reaction (PCR) was used to amplify specific regions of 
DNA. The reaction was carried out in a PCR tube in a final volume of 50 μl, 
comprising template DNA (~ 300 ng) , 1.5mM MgCl2, 0.15mM dNTP mix 
(consisting of dATP, dCTP, dTTP, dGTP), 1mM forward primer, 1 mM reverse 
primer, 1x Taq buffer  and 2.5 units Taq DNA polymerase (Bioline). The reaction 
was then run in a thermocycler (Biometra). The temperature of the thermocycler 
lid was set to 100˚C in order to prevent condensation on the lid of the PCR tube. 
The thermocycler was programmed as indicated below:  
 
Table 2.6: PCR cycling conditions when using Taq polymerase 
Temperature Step Time Cycles 
95C initial denaturation 5 minutes 1 
95C Denaturation 30 seconds  
25-35 
 
56C annealing 30 seconds 
74C Extension 1min/1Kb DNA to be amplified 
74C Final extension step 10 minutes 
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The annealing temperature was varied depending on the Tm of each primer. Tm 
was calculated using the equation: (annealing temperature) = 4 x (#G + #C) + 2 x 
(#A + #T). The PRC product was routinely analysed on a 1% agarose gel to 
confirm the presence of the product.                                                                          
2.8.6  Proofreading PCR  
Proofreading PCR was carried out using either the ACCUZYME
TM  
or Velocity 
proofreading DNA polymerase (supplied by Bioline) as follows:                              
Table 2.7: PCR reaction for ACCUZYME and Velocity polymerases 
Velocity ACCUZYME PCR reaction 
~300 ng ~300 ng Template DNA 
ـــــ 1.5mM MgCl2 
0.25mM 0.3mM dNTP mix 
2mM 1mM Forward primer 
2mM 1mM Reverse primer 
1x Velocity buffer 
which contains MgCl2 
1x ACCUZYME buffer DNA polymerase buffer 
2 units of Velocity 2.5 units of ACCUZYME DNA polymerase 
50μl 50μl Final volume 
  
 The PCR reaction (using ACCUZYME) was carried out with the same cycle 
programme described in table 2.6, but with an extension time of 2min/Kb DNA. 
For the reaction mixture using Velocity, the thermocycler was programmed 
slightly differently. The temperature of the initial denaturation step and the 
following denaturation steps was set at 98˚C and the extension time of the 
reaction was reduced to 30sec/Kb DNA.                                                                    
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  2.8.7  DNA ligation by T4 ligase 
The DNA ligation mixture was assembled on ice. The components were added 
together in a total volume of 21μl, comprising 2 μl of 10 x ligation buffer , 1μl  T4 
ligase  (3 units) and varying ratios of double- digested PCR product/linearised 
vector (~0.5 μg). For a negative control, the same protocol was followed in 
parallel with the exception that the PCR product was omitted. For a positive 
control, the plasmid DNA was linearised with only one restriction endonuclease 
and no PCR product was added. The reactions were placed in ice-cold water and 
left at room temperature overnight. (T4 DNA ligase was obtained from Promega). 
           
 
2.8.8  Sequencing of constructs 
 The sequencing of cloned constructs was performed by Beckman Coulter 
Genomics. This was performed on plasmid DNA prepared as described in section 
2.7.1.                                                                                                                           
 
2.9  Protein procedures 
2.9.1  Preparation of the samples of mevalonat pathway enzymes 
2×10
7
 amoebae were harvested by centrifugation at 1000rpm for 5minutes at 
room temperature. The supernatant was discarded and the pellet was resuspended 
in 10ml cold distilled water. The sample was then centrifuged (1000rpm, 
5minutes). The supernatant was discarded and the pellet resuspended in 1ml cold 
water. Protein samples were mixed with protein loading buffer (1:3) and heated at 
95ºC for ~5minutes. 
2.9.2  Preparation of D. discoideum cell lysates for investigations of the sterol 
biosynthesis enzymes                                                                                                 
Throughout the procedure, great care was taken to keep the samples at 0˚C. 2×108 
amoebae were centrifuged in a sterile pre-cooled 50 ml Falcon tube. All 
centrifugation steps were performed for 5 minutes at 1000 rpm and 4˚C. The 
supernatant was removed; the cells were washed in 40 ml of ice-cold distilled 
water and centrifuged. The supernatant was removed and the pellet was 
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resuspended in 10ml 50mM HEPES pH 7.5 at 0˚C. Subsequently, the cells were 
centrifuged again and the supernatant removed before, the cells were resuspended 
in 8ml 50mM HEPES pH 7.5. The suspension was transferred to a pre-cooled 
10ml beaker and sonicated on ice for 10 seconds at 10 amplitude microns in a 
Sanyo sonicater. Amoebal homogenates were kept on ice until used or stored at -
80˚C.                                                                                                                          
2.9.3 Treatment of peroxisomal membranes with sodium carbonate  
The protocol for extracting the peroxisomal membranes with sodium carbonate 
was adapted from (Fujiki et al., 1982, Elgersma et al., 1997). This method allows 
distinction between integral and peripheral membrane proteins by diluting the 
membranes in 0.1M Na2CO3 pH 11.4 at 0˚C. The amoebal homogenate (described 
in section 2.8.1) was centrifuged in a 10ml polycarbonate tube at 4˚C for 1 hour at 
50,000 rpm (~ 233,000 gmax) using a Beckman 50 Ti rotor. The supernatant was 
gently pipetted off and kept at 0˚C, until analyzed by SDS-PAGE or stored at -
80˚C. The pellet was resuspended in 100ml 0.1M Na2 CO3 pH 11.4 at 0˚C and 
incubated on ice for 30 minutes in order to dilute it to less than 10mg/ml protein. 
In these conditions, closed vesicles are converted into open sheets of membrane. 8 
ml of the suspension were centrifuged in a polycarbonate tube at 4˚C for 1 hour at 
50,000 rpm using a Beckman 50 Ti rotor. The supernatant was retained and 0.5 ml 
of it was concentrated by centrifugation using Millipore tube, with a 30 K cut-out, 
in a micro-centrifuge (13,000 rpm, 30 minutes, 4˚C). The final volume was made 
up to 0.04 ml with 50 mM HEPES pH 7.5 at 0˚C. The pellet was resuspended in 
0.64 ml 50 mM HEPES/ 1% Triton. Equivalent amounts (i.e. derived from the 
same number of cells) of each fraction were analysed on 10 % SDS-PAGE and 
Western blot analysis.                                 
2.9.4 Treatment of peroxisomal membranes with 1M NaCl  
Peripheral membrane proteins can be released from peroxisomal membranes by 
diluting the membranes in a high salt concentrations followed by high-speed 
centrifugation. Amoebal homogenate (described in 2.9.2) was centrifuged in a 
polycarbonate tube at 4˚C for 1 hour at 50,000 rpm using a Beckman 50 Ti rotor. 
All subsequent steps were carried out at 0˚C. The supernatant was separated from 
the pellet and was analysed on SDS-PAGE. The pellet was resuspended in 8 ml 
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1M NaCl in HEPES (50mM pH7.5) and incubated on ice for 30 minutes. The 
resulting suspension was centrifuged in a polycarbonate tube at 4 ˚C for 1 hour at 
50,000 rpm (Beckman 50 Ti rotor). The supernatant was pippeted off. 0.25 ml 
40% TCA (trichloroacetic acid) was added to a 0.75ml sample of supernatant in 
an Eppendrof tube to precipitate protein. The sample then was incubated on ice 
for 30 minutes and subsequently centrifuged in a micro-centrifuge (13,000 rpm, 5 
minutes, 4˚C). The supernatant was removed and the pellet was mixed with10μl 
1M Tris pH 10.9. The mixture was diluted (×10) in protein loading buffer (250 
mM Tris-Cl pH 6.8, 9.2 % (w/v) SDS, 40 % (v/v) glycerol, 0.2 % (w/v) 
bromophenol blue, 0.1 M DTT). The membrane pellet was resuspended in 8 ml 50 
mM HEPES/1% (v/v) Triton. The samples were examined by 10 % SDS-PAGE 
and Western blot analysis.                                                                                           
 
 2.9.5 Protein separation by sodium dodecyl sulphate-polyacrylamid gel 
electrophoresis (SDS-PAGE)                                                                                   
Proteins were analysed by SDS-PAGE according to the metod of (Lamemmli et 
al, 1970). A 10% resolving gel  was made from a stock solution consisting of the 
following:              
Table 2.8: Composition of the resolving gel                                                      
Stock solution 10% Resolving gel 
Protogel ( polyacrylamide  30 % (w/v)/ 0.8 
% (w/v) bis-acrylamide) 
6.6 ml 
Resolving gel buffer (1.5 M Tris-HCl, 0.4% 
SDS,  pH 8.8) 
5.2 ml 
Distilled water 8.2 ml 
10 % (w/v) ammonium persulphate (APS) 200 µl 
N,N,N',N'-tetramethylethylenediamine 
(TEMED) 
20 µl 
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The above components were mixd and poured between 1.5mm glass plates. The 
resolving gel surface was overlaid with isopropanol and allowed to polymerize. 
Once, the resolving gel had set, the isopropanol was removed. Subsequently, a 
stacking gel was added and a 1.5mm comb immediately inserted. The stacking gel 
consisted of the following:                                                                                          
Table 2.9: Composition of the stacking gel                                                           
Stock solution Stacking gel 
Protogel ( polyacrylamide  30 % (w/v)/ 
0.8 % (w/v) bis-acrylamide) 
2.6 ml 
Stacking gel buffer (0.5 M Tris-HCl, 
0.4% SDS,  pH 6.8) 
5 ml 
Distilled water 12.2 ml 
10 % (w/v) ammonium persulphate (APS) 200 µl 
N,N,N',N'-tetramethylethylenediamine 
(TEMED) 
20 µl 
 
When the stacking gel had polymerized, the plates containing the gel were placed 
into an electrophoresis tank (Bio-Rad Mini-PROTEAN
®
) which was filled with 
1x running buffer (25mM Tris; 250mM glycine; 0.1% (w/v) SDS). Protein 
samples were mixed with protein loading buffer (250 mM Tris-Cl pH 6.8, 9.2 % 
(w/v) SDS, 40 % (v/v) glycerol, 0.2 % (w/v) bromophenol blue, 0.1 M DTT) and 
heated at 95ºC for ~5minutes. The samples were loaded onto the gel alongside a 
pre-stained protein marker (BioRad). Electophoresis was performed at constant 
voltage (150 V) and was continued until the marker dye had migrated to the 
bottom of the resolving gel.                                                                                        
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2.9.6 Western Analysis                                                                                              
Protein samples,  separated by SDS-PAGE, were transferred to a nitrocellulose 
membrane to allow detection of the desired proteins using specific antibodies. The 
transfer process was carried out in pre-cooled transfer buffer (25 mM Tris; 150 
mM glycine, pH 8.3; 40% (v/v) methanol) for 2 hours at constant current (200 
mA), using a Mini Trans Blot Electrophoretic Transfer Cell (Bio-Rad), as 
described in the Bio-Rad manual. In order to confirm that the proteins had been 
transferred successfully, the membrane was soaked in Ponceau S staining solution 
(0.1 % (w/v) Ponceau S in 5 % (v/v) acetic acid) for ~5 minutes. Alternatively, the 
pre-stained protein marker can give a visual indication of the success of the 
transfer. 
 
2.9.7 Detection of proteins on western blots 
Once the nitrocellulose membrane had been blotted, the membrane was soaked in 
blocking buffer (2 % (w/v) skimmed milk in 1×TBS from a stock solution 
comprising 50 mM Tris, 150 mM NaCl, pH 7.4) and placed on a shaking table at 
room temperature for 1hour. Next, the membrane was incubated in fresh blocking 
buffer containing an appropriate dilution of the primary antibody (determined 
experimentally) for 1hour. The previous mixture was removed and the membrane 
was washed three times in 1×TBS/ 0.1% (v/v) Polysorbate 20 (Tween 20) with 
each wash lasting 10 minutes. The membrane was then incubated in fresh 
blocking buffer containing an appropriate dilution of the secondary antibody for 
1hour. The membrane was washed with distilled water and the proteins detected 
by using the EZ-ECL Chemiluminescence detection kit (Biological Industries), 
according to the manufacturer’s instructions.                       
 
2.9.8 Sources of antibodies 
Monoclonal primary antibody against GFP (Anti_GFP IgG) used in section 2.9.7 
was obtained from Roche. Horseraddish peroxidase (HRP)-conjugated goat anti-
mouse IgG (Sigma-Aldrich, UK) was used as the secondary antibody.  
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Chapter 3 
Investigations of the intracelluar locations of the 
mevalonate pathway enzymes in Dictyostelium discoideum 
 
3.1 Introduction 
In Dictyostelium discoideum a number of the mevalonate pathway enzymes 
possess a PTS. This implies that part of the mevalonate pathway may take place in 
the peroxisomes. Furthermore, it was found previously that D. discoideum FDP-
synthase, which catalyzes the final two steps of the mevalonate pathway, is 
directed to the peroxisomes by making use of the PTS2-dependent pathway 
(Nuttall et al., 2012). This enzyme is of particular interest because it is the target 
of nitrogen –containing bisphosphonates drugs (NBPs) (Grove et al., 2000). The 
therapeutic application of these drugs is to inhibit osteoclast-mediated bone 
resorption and therefore the drugs are used to treat metabolic bone diseases such 
as osteoporosis, tumoral bone disease and Paget’s disease in which bone 
resorption is excessive (Fleisch., 1995). The observation that FDP-synthase is the 
target of the NBPs was originally made in the cellular slime mould D. discoideum. 
This organism was used as a model system for investigating the mechanism of 
action of NBPs because the drugs inhibit its growth apparently in the same way 
that they inhibit osteoclast-mediated bone resorption (Rogers et al., 1994, Rogers 
et al., 1995).  
The peroxisomal localization of D.discoideum FDP-synthase was identified 
successfully by transforming D.discoideum amoebae to express a fusion protein 
between the FDP-synthase and GFP, the GFP fluorescence then being localized to 
the peroxisomes. Furthermore, it was found that the fusion protein was 
catalytically active and this proved that the enzyme was folded properly in the 
amoebae (Nuttall et al., 2012).  
By contrast, in mammalian cells, attempts to determine the intracellular location 
of the mevalonate pathway enzymes by expressing each as a GFP-fusion protein 
were largely unsuccessful (Kovacs et al., 2007, Hogenboom et al., 2004c).  
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These results were obtained probably because the tagged enzymes could not fold 
properly and as a result formed aggregates in the cytosol. Thus, identification of 
the intracellular location of the pathway enzymes had to rely on use of antibodies. 
Despite the frequent use of immunochemical methods, they can be unreliable 
because the antibodies are not sufficiently specific for their antigen.  In addition, a 
further difficulty of using immunochemical methods is that the antibodies can 
only bind to their target when it is present in a sufficiently high concentration (i.e. 
antibodies usually cannot detect cytosolic enzymes because they are at too low a 
concentration).  
Since the GFP-tagged FDP-synthase folded correctly in D.discoideum, it seemed 
possible that the intracellular location of the other mevalonate pathway enzymes 
in D. discoideum amoebae might be established by transforming amoebae to 
express each enzyme fused to GFP. I used GFP as this is a bright and stable 
fluorescent protein that is widely used for subcellular localization studies in living 
cells. For double labeling we used a D. discoideum optimised red fluorescent 
protein (mRFP) (Fischer et al., 2004). Thus, the aim of this chapter is to describe 
investigations of the intracellular locations of the pathway enzymes in D. 
discoideum by generating GFP fusion proteins and analyzing the intracellular 
distribution of the transformed amoebae by fluorescence microscopy.  
Tagging of proteins with GFP or mRFP may affect their localization. However, if 
fusion proteins are targeted to peroxisomes, we will conclude that the enzyme has 
the targeting information for this organelle. No examples have been reported 
where a fusion protein is mistargetted to peroxisomes.  If fusion proteins are 
localized to the cytosol, the interpretation is more difficult since the tags might 
interfere with localization to peroxisomes or other places in the cell. 
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3.2  Results 
3.2.1   The intracellular location of 3-Hydroxy-3-Methylglutaryl-Coenzyme A 
Synthase                                                                                                                     
HMG-CoA synthase catalyzes the second reaction in the biosynthesis of 
isoprenoids by adding acetyl-CoA to acetoacetyl CoA to form HMG-CoA. In 
mammalian cells, there are two genes encoding HMG-CoA synthase. One gene 
was identified as a mitochondrial enzyme required for ketogenesis (Hegardt, 
1999). The other enzyme was believed to be localized to the cytosol (Ayte et al., 
1990). However, it has been reported that HMGS is directed to the peroxisomes 
by use of  PTS2-dependent pathway (Olivier et al., 2000).                                      
D. discoideum amoebae possess two different HMG-CoA synthase genes HMGS 
(A) and HMGS (B). HMG-CoA synthase (A) has neither a PTS1 nor a PTS2. In 
order to determine the subcellular location of the enzyme, a GFP-fusion protein 
was generated with the GFP at the C-terminus. The 1449bp DNA fragment was 
amplified by PCR from the D. discoideum cDNA library by using VIP 1958 and 
1959 as primers (section 2.3 in the materials and methods).  After digestion with 
XhoI and BamHI, the DNA fragment of Dd HMGS (A) was ligated into XhoI-
BamHI digested pMAA1to give pMA01. Amoebae transformed with pMA01 
expressed DdHMGS (A)–GFP and the fluorescence was in the cytosol (Figure 
3.1) indicating that this enzyme is cytosolic.  
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Figure 3.1: The intracellular localization of D.discoideum HMG-CoA 
synthase (A). Amoebae overexpressing the full-length DdHMG-CoA synthase 
(A)-GFP show a distribution of green fluorescence in the cytosol. Bright field 
(BF) shows cell morphology. Scale bars 5µm.   
 
In D. discoideum, HMG-CoA synthase (B) contains a consensus PTS1 (-Ser-Lys-
LeuCOOH) located at the C-terminus. The GFP-fusion protein was generated 
without masking the amino acid triplet at the carboxy terminus. The open reading 
frame of Dd HMGS (B) was amplified by PCR from the D. discoideum cDNA 
library using VIP 1960 and VIP 1961. The resulting fragment (1407bp) was 
ligated into BamHI-Xbal digested pDXA3C-MA to produce pMA02. When 
amoebae co-expressing pMA02 (encoding GFP- Dd HMGS (B)) and the 
peroxisomal marker mRFP-PTS1 the pattern of GFP fluorescence was punctate 
and superimposable on the fluorescence pattern of mRFP (Figure 3.2). Therefore, 
it appeared that HMGS (B) is a peroxisomal enzyme in D. discoideum.    
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Figure 3.2: Demonstration of the peroxisomal location of DdHMG-CoA 
synthase (B). Amoebae were expressing both GFP- DdHMG-CoA synthase (B) 
(green) and a peroxisomal marker mRFP-PTS1 (red). The green fluorescence of 
DdHMG-CoA synthase (B) is co-localized with the red fluorescence of the 
peroxisomal marker (mRFP-PTS1). Since peroxisomes have a tendency to move 
during the imaging it appeared that the patterns of green and red fluorescence are 
not completely co-localized. Scale bars 5µm.   
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3.2.2  Hydroxy-3-Methylglutaryl-Coenzyme A Reductase is localized to the 
endoplasmic reticulum 
In D. discoideum there are two different genes encoding HMG-CoA reductase 
(HMGR1 and HMGR2). The amino terminus of each gene comprises 
hydrophobic and charged amino acids resembling a signal peptide. In mammalian 
cells it has been shown that HMG-CoA reductase is localized to the endoplasmic 
reticulum (Goldfarb, 1972, Liscum et al., 1985) although it has been suggested 
that the human enzyme is also peroxisomal (Kovacs et al., 2007, Keller et al., 
1986, Krisans, 1996). A dual localization of Arabidopsis HMG-CoA reductase 
has also been observed (Leivar et al., 2005). Although Arabidopsis HMGR is 
localized to the ER, it is also clearly within spherical vesicular structures which 
are located in the cytoplasm and within the vacuole.  
To verify the intracellular location of D. discoideum HMGR1 and HMGR2, we 
generated a C-terminal GFP-fusion protein for each isozyme as N-terminal 
fusions are likely to interfere with targeting to the ER. The full length of 
DdHMGR2 was amplified by PCR from the cDNA by use of primers VIP 1409 
and VIP 1410. The 1581bp DNA fragment was digested with XhoI and BamHI 
and ligated into linearised pMAA-1 to obtain pMA04. The resulting plasmid 
encoded HMGR2 joined to GFP by a linker sequence comprising Ser-Thr-Ser-
Thr. In amoebae expressing DdHMGR2-GFP a punctate distribution of 
fluorescence was observed (Figure 3.3). However, in amoebae co-expressing 
DdHMGR2-GFP and the peroxisomal marker mRFP-PTS1 (monomeric red 
fluorescent protein having –SKL at the C-terminus), the pattern of GFP 
fluorescence was different from the pattern given by the mRFP (Figure 3.4). Thus, 
it was apparent that HMGR2 is not a peroxisomal enzyme. 
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Figure 3.3: Analysis of the DdHMGR2-GFP in D.discoideum. The green 
fluorescence in amoebae expressing the fusion protein DdHMGR-2-GFP was 
punctate. Scale bars 5µm.   
 
 
Figure 3.4: DdHMGR2-GFP is not a peroxisomal enzyme in D.discoideum.  
Amoebae co-expressing DdHMGR2-GFP and the peroxisomal marker mRFP-
PTS1 showed two entirely different patterns of fluorescence. Scale bars 5µm.      
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In order to investigate further the location of DdHMGR2, we generated an ER 
marker pMA25 encoding protein disulfide isomerase (PDI) tagged at its C-
terminus with mRFP. The PDI had been identified as an endoplasmic reticulum 
resident enzyme in D. discoideum despite its  lacking an ER-retrieval signal 
(Monnat et al., 1997). Amoebae co-expressing DdHMGR2-GFP and PDI-mRFP 
showed a punctate distribution of GFP fluorescence which was superimposable on 
the fluorescence pattern of the ER marker (Figure 3.5). Thus, DdHMGR2-GFP is 
localized to the ER in D. discoideum.  
 
 
Figure 3.5: Demonstration of the ER localization of DdHMGR2. When 
amoebae co-expressed DdHMGR2-GFP and the ER marker PDI-mRFP, there was 
complete co-localization of the GFP and mRFP fluorescence. Scale bars 5µm.      
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Similarly, we investigated the intracellular location of DdHMGR1 by generating a 
GFP-fusion protein. It was found that the initial part of the 5´ end (approximately 
62 nucleotides) of the DdHMGR1 cDNA was missing from the cDNA in two 
separate D. discoideum cDNA libraries. Therefore, the full length DdHMGR1 
cDNA was obtained by using oligonucleotide VIP 1753, comprising the first 83 
nucleotides and VIP 1408. The DNA fragment was digested with XhoI and 
BamHI and ligated into XhoI-BamHI digested pMAA-1 to give pMA03. When 
amoebae expressed DdHMGR1-GFP, a punctate pattern of fluorescence was 
observed (Figure 3.6). In amoebae co-expressing DdHMGR1-GFP and PDI-
mRFP the patterns of GFP and mRFP fluorescence were superimposable (Figure   
3.7). Furthermore, the PDI-mRFP fluorescence was in the form of variably-sized 
spots exactly matching the DdHMGR1-GFP fluorescence. It was therefore 
concluded that DdHMGR1 is also associated with the ER.  
 
Figure 3.6: Analysis of the DdHMGR1-GFP fusion protein in D.discoideum. 
Amoebae expressing the fusion protein DdHMGR1-GFP exhibited a punctate 
pattern of GFP fluorescence. Scale bars 5µm.   
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Figure 3.7: The intracellular localization of D.discoideum HMGR1. Amoebae 
expressing DdHMGR1-GFP contained fluorescent vesicles of different sizes. The 
GFP fluorescence co-localized with the fluorescence of an ER marker (mRFP-
PDI). Scale bars 5µm.   
In the plant Arabidopsis, spindle-shaped (fusiform) organelles were observed after 
overexpressing ER-targeted GFP and it had been suggested that this structure 
arises owing to inclusion of so much enzyme within the lumen of the ER ( 
Gunning 1998, Hawes et al., 2001). In addition, it has been reported that 
overexpressed membrane-targeted GFP fusion proteins cause formation of 
organelle aggregates (Lisenbee et al., 2003).  Since D. discoideum immunoblots 
indicated that DdHMGR1 seems to behave as an integral membrane protein (see 
section 3.2.3 below), it is difficult to explain the observed pattern of fluorescence 
given by DdHMGR1-GFP but, possibly as suggested by Lisenbee et al, 2003, it is 
caused by organelle aggregation.   
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3.2.3 The membrane association of HMG-CoA Reductase in D. discoideum 
In D.discoideum HMGR1 possesses three predicted transmembrane domains 
(TMD) as predicted by phyre2. Two of them located near the N-terminus 
extending from residues 18-33 and 52-66. The third TMD is located near to the C- 
terminus (amino acid residues 517-533). However, DdHMGR2 does not seem to 
have a predicted TMD. In order to investigate the membrane association of 
DdHMGR1 and DdHMGR2, amoebae were disrupted by sonication and the 
suspension centrifuged at ~233,000 gmax for 1 hour. The pellet was then treated 
with 100mM sodium carbonate followed by high speed centrifugation ~ 233,000 
gmax (section 2.9.3 Materials and Methods), a treatment that is believed to separate 
the lumenal proteins, which are found in the supernatant from the integral 
membrane proteins which remain associated with the membrane fraction (Fujiki et 
al., 1982).  It was found that DdHMGR2 was released into the supernatant after 
the treatment with carbonate, whereas the DdHMGR1 could not be extracted with 
Na2CO3 pH 11.4. These results suggested that DdHMGR1 is very strongly 
associated with the ER membrane and could be an integral membrane protein 
(Figure 3.8). By contrast, DdHMGR2 behaves as a luminal protein but it is 
possible that it is loosely bound to the ER membrane (Figure 3.8). These results 
are in agreement with the bioinoformatic predictions.  
 
Figure 3.8: Association of D. discoideum HMG-CoA Reductases with the ER 
membrane. Amoebal homogenate was centrifuged at 4 ˚C for 1 hour at 50,000 
rpm using a Beckman 50 Ti rotor. The supernatant (first s) was separated from the 
pellet and subjected to SDS- PAGE and western blot analyses using an anti-GFP 
antibody. The pellet fraction was extracted with 100mM Na2CO3 pH 11.4. 
Extracted proteins were separated from the membrane by high speed 
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centrifugation (~ 233,000 gmax). Samples of the pellet and supernatant (final s) 
fractions were analyzed by immunoblot analyses using the anti-GFP antibody. 
Each sample on the immunoblot was derived from the same number of cells.                                    
3.2.4  Mevalonate kinase fusion proteins are localized to the cytosol 
The amino-terminal region of D. discoideum mevalonate kinase (DdMVK) 
contains a putative PTS2 (KIILFGEHA) (Table 3.1). We generated two GFP 
fusion proteins to determine the intracellular location of DdMVK. The first 
comprised DdMVK linked to the amino-terminus of GFP. The DNA fragment 
amplified from the D. discoideum cDNA library by using primers VIP 1269 and 
VIP 1270 (section 2.3 in the Materials and Methods) encoded DdMVK with the 
addition of the carboxy-terminal amino acids sequence Ser-Thr-Ser-Thr. This 
DNA fragment was digested with HindIII and BamHI and inserted into HindIII-
BamHI digested pGFP. The resulting plasmid was named pMA05.  
The second construct, which comprised DdMVK joined to the C-terminus of 
GFP, was generated similarly. A DdMVK cDNA, with the addition of the N-
terminal amino acids sequence Ser-Thr-Ser-Thr, was amplified by PCR using 
pMA05 as the DNA template and VIP 1361 plus VIP 1362 as primers and ligated 
as a BamHI-XbaI fragment into the PDXA3C-MA vector to give pMA06. 
Fluorescence in amoebae transformed with either of the two constructs was in the 
cytosol (Figure 3.9). Hence, it appears that the putative PTS2 does not direct 
DdMVK to the peroxisomes. 
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Figure 3.9: Localization of D. discoideum mevalonate kinase. A) Amoebae 
transformed to express the GFP-DdMVK fusion protein. B) Amoebae transformed 
to express the DdMVK-GFP fusion protein. In both case a cytosolic distribution 
of green fluorescence was observed. Scale bars 5µm.   
Table 3.1: Sequence of the putative PTS2 within mevalonate kinases from 
different organisms. 
(A) (B) 
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In mammals, MVK contains a consensus PTS2 (e.g. KVILHGEHA in the rat 
enzyme) which was found to target the enzyme into the peroxisomes (Kovacs et 
al., 2007). However, the cytosolic localization of DdMVK is in agreement with 
the previous studies identifying the localization of Catharanthus roseus and 
Arabidopsis thaliana MVK to the cytosol (Simkin et al., 2011).  Furthermore, five 
proteins in mice, apparently possessing a consensus PTS2, have been identified by 
a bioinformatics approach but none of them is directed to the peroxisome (Mizuno 
et al., 2008). A consensus PTS2 sequence is present near to the amino-terminus of 
some archaebacteria and eubacteria MVK even though bacteria lack peroxisomes 
(Houten et al., 2000). This evidence would imply that a putative PTS2 sequence 
does not necessarily direct a protein into the peroxisomes, as appears to be the 
case for the DdMVK. 
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3.2.5 The GFP-Phosphomevalonate kinase fusion protein is localized to the 
peroxisome 
The D. discoideum phosphomevalonate kinase (DdPMK) contains a putative 
PTS1 (-Pro-Lys-LeuCOOH) at the C-terminus whereas the N-terminus of DdPMK 
does not seem to contain any putative targeting signal. Therefore, the intracellular 
location of DdPMK was determined by generating a GFP fusion protein without 
masking the putative PTS1 at the carboxy-terminus. The open reading frame of 
DdPMK was amplified by PCR from the cDNA library using VIP 1267 and VIP 
1268. This DNA fragment encodes DdPMK, with the addition of the N-terminal 
amino acid linker sequence Ser-Thr-Ser-Thr, was digested and ligated into 
BamHI-XbaI digested pDXA3C-MA. The resulting plasmid, pMA07, encoded 
GFP-DdPMK. In amoebae expressing pMA07 a punctate distribution of 
fluorescence was observed suggesting that DdPMK is peroxisomal (Figure 3.10). 
 
Figure 3.10: Analysis of the GFP-DdPMK fusion protein in D.discoideum. 
Amoebae transformed to express GFP-DdPMK show a punctate pattern of GFP 
fluorescence. Scale bars 5µm.   
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To confirm the peroxisomal location, the amoebae were re-transformed to express 
the peroxisomal marker mRFP-PTS1. The punctate fluorescence of DdPMK and 
the peroxisomal marker co-localized (Figure 3.11). Thus, it could be concluded 
that DdPMK is localized to peroxisomes.  
 
 
Figure 3.11: Demonstration of the peroxisomal localization of DdPMK. 
Amoebae were transformed with two plasmids to express both GFP-DdPMK 
(green) and the peroxisomal marker mRFP-PTS1 (red). Co-localization of the 
GFP and mRFP fluorescence in the peroxisomes was observed. Scale bars 5µm.   
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3.2.6 D. discoideum phosphomevalonate kinase is imported into the 
peroxisomes by use of its PTS1 (-PKL) 
To investigate whether the putative PTS1 is essential for DdPMK localization to 
peroxisomes, two constructs were generated. The first construct (PMA09) was 
generated to encode a GFP-DdPMK fusion protein in which the last three amino 
acids corresponding to the PTS1 of DdPMK had been removed. When amoebae 
were transformed with this construct, the fluorescence indicated that the 
DdPMKΔPTS1 was cytosolic (Figure 3.12).  
 
 
Figure 3.12: Analysis of the GFP-DdPMKΔPTS1 fusion protein in D. 
discoideum. Amoebae transformed to express GFP-DdPMKΔPTS1 showed green 
fluorescence throughout the cytosol. Scale bars 5µm.   
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In the second construct, oligonucleotides VIP 1372 and VIP 1373, encoding the 
last 12 amino acids of DdPMK including the putative PTS1 
(VAIDMSHITPKLCOOH), were annealed and ligated into BamHI and XbaI 
digested pDXA3C-MA to give pMA08 (Figure 3.13). When amoebae were 
transformed with this construct, a typical punctate pattern of peroxisomal 
fluorescence was observed (Figure 3.14). Hence, use of these two constructs 
confirmed that DdPMK localizes to peroxisomes by making use of a PTS1 (-
PKL). 
 
 
Figure 3.13: Schematic structure of pMA08 which consisted of the putative 
PTS1 of DdPMK added to the C-terminus of GFP.   
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Figure 3.14: The C-terminal PTS1 of DdPMK is responsible for directing the 
fusion protein into the peroxismes. Amoebae transformed to express the last 12 
amino acid residues of DdPMK fused to GFP displayed a typical peroxisomal 
pattern. Scale bars 5µm.   
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3.2.7 Diphosphomevalonate Decarboxylase fusion proteins  are cytosolic in D. 
discoideum 
In D. discoideum, diphosphomevalonate decarboxylase (DdDMPD) has neither a 
PTS1 nor a PTS2. The intracellular location of DdDMPD was investigated by 
expressing the enzyme, fused C-terminally to GFP, in amoebae. The full length 
DdDMPD cDNA was amplified by PCR from the cDNA library by using primers 
VIP 1253 and VIP 1254. This DNA fragment was digested with HindIII and 
BamHI and ligated into HindIII-BamHI digested pGFP to obtain pMA11. When 
this construct was expressed in D discoideum amoebae, the GFP fluorescence was 
observed in the cytosol (Figure 3.15 A). pMA10, encoding DdDMPD tagged with 
GFP at its N-terminus, was generated similarly.  The fluorescence of the GFP was 
again observed in the cytosol (Figure 3.15 B). Thus, these results indicated that 
DdDMPD is not peroxisomal in D. discoideum. This observation is entirely 
consistent with the absence of a PTS from this enzyme.  
 
 
 
Figure 3.15: The intracellular location of D. discoideum 
diphosphomevalonate decarboxylase. Amoebae were transformed to express 
either DdDMPD-GFP (A) or GFP-DdDMPD (B). The pattern of fluorescence 
indicates a cytosolic distribution for the fusion proteins. Scale bars 5µm.   
 
(A) (B) 
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3.2.8 Isopentenyl Diphosphate: Dimethylallyl Diphosphate (IDP) Isomerase 
fusion proteins are localized to the cytosol in Dictyostelium discoideum 
It has been claimed that the hamster (Mesocricetus auratus) IDP-isomerase is a 
peroxisomal enzyme and that it is directed to the peroxisome by an unusual PTS1 
(-His-Arg-MetCOOH). There is a similar C-terminal triplet (-His-Arg-TyrCOOH) in 
the Dictyostelium discoideum IDP-isomerase. This amino acid triplet of IDP-
isomerase is identical in several species of slime mould (Figure 3.16) which 
implied that the DdIDP-isomerase might also be peroxisomal enzyme.   
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Figure 3.16: Alignment of the amino acid sequences of isopentenyl 
diphosphate isomerase from related species of slime moulds. (1) Dictyostelium 
fasciculatum. (2) Polysphondylium pallidum (3) Dictyostelium discoideum (4) 
Dictyostelium purpureum. The isomerase from all four species has a putative 
PTS1 (-HRY).  
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The intracellular location of DdIDP-isomerase was first investigated by 
generating a construct comprising DdIDP-isomerase tagged at its N-terminal end 
with GFP to avoid masking the putative PTS1.  The proof-reading enzyme 
Accuzyme and the primers VIP 1288 and VIP 1289 were used to amplify the 
DdIDP-isomerase cDNA from the D. discoideum cDNA library. The resulting 
DNA fragment was ligated into PDXA3C-MA immediately downstream of the 
sequence encoding GFP by using the BamHI and XbaI restriction sites to obtain 
pMA12. Wild type amoebae were transformed with the pMA12 to express the 
GFP-DdIDP isomerase. The fluorescence of the fusion protein was localized to 
the cytosol (Figure 3.17 A). It thus appeared that the amino acid triplet (–HRY) at 
the C-terminus of DdIDP-isomerase does not act as a PTS1. Although the N- 
terminus of IDP-isomerase in D.discoideum appears not to contain a putative 
PTS2, a second construct (pMA13) was generated to encode DdIDP-isomerase-
GFP.  pMA13 was constructed by ligating the full length DdIDP-isomerase cDNA 
into HindIII-BamHI digested pGFP. When D. discoideum amoebae were 
transformed with this construct, the GFP fluorescence indicated that the DdIDP-
isomerase-GFP fusion protein again remained in the cytosol (Figure 3.17 B). 
 
 
Figure 3.17: The intracellular location of DdIDP-isomerase. Amoebae 
transformed to express either GFP-DdIDP-isomerase (A) or DdIDP-isomerase-
GFP (B) exhibit green fluorescence in the cytosol. Scale bars 5µm.   
 
(A) (B) 
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3.2.9 Generating IDP-isomerase internal GFP fusion protein 
In Arabidopsis there are two genes for IDP-isomerase and the pre-mRNA 
transcribed from each gene can be processed to give either a long or short isform. 
Recent studies have shown that the two short versions of IDP-isomerase are 
localized to peroxisomes (Sapir-Mir et al., 2008). These have a putative PTS1 (- 
HKL) at the  C-terminus. However, both GFP-IDP isomerase fusion proteins 
localized to the cytosol. Furthermore, when the short versions of IDP-isomerase 
were tagged with GFP at the C-terminal end, the fusion proteins again remained in 
the cytosol (Nakamura et al., 2001, Okada et al., 2008, Phillips et al., 2008). 
However, a peroxisomal localization for Arabidopsis IDP-isomerase was obtained 
for a fusion protein in which the GFP was placed ten amino acids from the C-
terminal end of the IDP-isomerase. It was concluded that sequences at both the N-
terminal and C-terminal ends of the short versions of Arabidopsis IDP-isomerase 
are needed to direct the enzymes to the peroxisomes.  
To determine whether both C-terminal and N-terminal sequences in the D. 
discoideum IDP-isomerase direct the enzyme to the peroxisomes, an internal GFP 
fusion was produced. First, the full length IDP-isomerase (700bp) was amplified 
by PCR from pMA13 by using primers VIP 1418 and VIP 1419. This DNA 
fragment was ligated between the HindIII and KpnI sites of digested pDXA3C. 
Then, the full length GFP cDNA was amplified by PCR from pMA13 using 
primers VIP 1420 and VIP 1421. This DNA fragment was inserted downstream of 
the IDP-isomerase between the SacI and XhoI restriction sites. Finally, a DNA 
fragment encoding the final 12 amino acids of the carboxy-terminus of DdIDP-
isomerase and containing the potential PTS1 (-HRY) was added between the XhoI 
and XbaI sites (Figure 3.18).  Amoebae were transformed with the final construct 
(pMA14) to allow expression of the internal GFP fusion protein. The tagged 
DdIDP-isomerase still remained in the cytosol (Figure 3.19). Hence, IDP-
isomerase does not appear to be a peroxisomal enzyme in D. discoideum.  
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Figure 3.18: Schematic structure of pMA14 which encodes Dd IDP-isomerase 
with an internal GFP tag.                                                                                        
 
 
Figure 3.19: Localization of DdIDP-isomerase having an internal GFP tag. 
Amoebae expressing DdIDP-isomerase with an internal GFP tag exhibited 
fluorescence indicating that the fusion protein is cytosolic. Scale bars 5µm.   
 
 
 
 
 
pMA14 
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3.2.10 Expression of mRFP terminating in the triplet –HRY                              
A further experiment was carried out to investigate whether the putative PTS1-
sequence (-HRY) is able to target the red fluorescent protein to the peroxisomes. 
pmRFP (Nuttall et al., 2012) was modified so that it encoded mRFP attached to 
the eight C-terminal amino acids (PTNTIHRYCOOH) of DdIDP-isomerase. When 
amoebae were transformed with this plasmid, the mRFP was localized in the 
cytosol (Figure 3.20). By contrast, it had previously been shown that mRFP 
having the consensus PTS1 sequence SKL at its C-terminus is peroxisomal 
(Nuttall et al., 2012). Hence, it was apparent that the triplet –HRY is not a 
functional PTS1 in D. discoideum.                                                                                                                 
 
 
Figure 3.20: The C-terminal PTS1 of DdIDP-isomerase is not functional. 
Amoebae transformed to express the eight C-terminal amino acid residues of 
DdIDP-isomerase fused to mRFP exhibited a pattern of fluorescence indicating 
that the fusion protein is cytosolic. Scale bars 5µm.    
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3.2.11  Demonstration that the three cytosolic mevalonate pathway enzymes 
DdMVK, DdMPD and Dd IDP-isomerase, expressed as GFP-fusion proteins 
in D. discoideum, were full length                                                                             
To confirm that these three enzymes were not accumulating in the cytosol owing 
to partial degradation and loss of peroxisome-directed signal sequences, it was 
necessary to demonstrate that full length GFP-fusion proteins were accumulating 
in the cytosol in D. discoideum amoebae. Immunoblot analyses were therefore 
performed. Amoebal extracts (section 2.9.1 in the Materials and Methods) were 
analyzed by SDS-PAGE and western blotting, the GFP tags being detected by use 
of a monoclonal antibody. GFP was used as a control protein. In each case, a 
protein of the expected molecular weight was detected (Figure 3.21). 
Furthermore, there was little evidence for accumulation of breakdown products. 
These results indicated that it was the intracellular location of each full-length 
enzyme in amoebae that had been determined in the previous experiments making 
use of fluorescence microscopy.  
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Figure 3.21: Immunoblot analyses of mevalonate pathway enzymes fused to 
GFP. (A) Mevalonate kinase-GFP (B) Diphosphomevalonate decarboxylase-GFP 
(C) GFP-IDP-isomerase (D) IDP-isomerase internal GFP.    
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3.3 Discussion 
The use of the GFP/mRFP tagged enzyme approaches allowed us to determine the 
intracellular locations of the mevalonate pathway enzymes in Dictyostelium 
discoideum amoebae. It has previously been shown that FDP-synthase is a 
peroxisomal enzyme in D.discoideum (Nuttall et al., 2012). Furthermore, in this 
chapter a peroxisomal location for both the second isozyme of HMG-CoA 
synthase and phosphomevalonate kinase has been identified. As in other 
organisms, both HMG-CoA reductases seem to be associated with the ER. 
Finally, four enzymes of the mevalonate pathway (i.e. HMG-CoA synthase (A), 
mevalonate kinase, diphosphomevalonate decarboxylase and IDP-isomerase) 
were appeared to be ctosolic (Table3.2).                                                                       
Enzyme 
location 
The 
Putative 
PTS 
C-terminal 
sequence 
N-terminal sequence Enzyme  
Cytosol NO PTS 
 
RATKSVLSIL MTKPENIGIH 
GIEVYFPSTY 
VAQEDLEKFD 
HMGS (A) 
Peroxisome PTS1 KSKPIISSKL MKKTKDIGIC 
AIDIYFPQTY 
VNQSELKKYD 
HMGS (B) 
 
ER NO PTS 
 
HLQYNRAKTN MLFAPPNLET 
KELFWIIYILIL 
IPKVFAKV    
HMGR1 
ER NO PTS 
 
SMTHNLPHSD MIRIGSNLIK 
QSIKNTNKSG 
ISRFFTTGSN  
HMGR2 
Cytosol 
 
PTS2 VSINILPIQK MISNQDNIIQ 
VSAPGKIILF 
GEHAVVLEKT 
MVK 
 
Peroxisome  
 
PTS1 IDMSHITPKL MERVVCSAPG 
KVLVTGGYLV 
LDKKYDGIVF 
PMK 
 
Cytosol 
 
NO PTS 
 
NTTGLPKQLN MVLASVTCTA 
PVNIAVIKYW 
GKRDENIILP 
DPMD 
 
Cytosol PTS1 VEPTNTIHRY MATKSNEENI 
AEFKGHNEIQ 
IELMKEECIV 
 IDP- isomerase 
    
Peroxisome  
 
PTS2 LSKIYKRDL MNNQSLQRAA 
MISEHLAPTS 
 FDP-synthase 
  
84 
 
 
Table 3.2: The intracellular locations of the mevalonate pathway enzymes in 
Dictyostelium discoideum based on fusion protein studies.                                                                                        
 
Both DdHMGS(B) and phosphomevalonate kinase possess a putative PTS1 SKL 
and PKL at the C-terminus respectively. The amino acid triplet Ser-Lys-Leu is a 
highly efficient peroxisomal targeting signal and when GFP tagged at the C-
terminus with Ser-Lys-Leu was expressed in amoebae, a typical peroxisomal 
pattern of fluorescence was observed (Nuttall et al., 2012). The C-terminal 
tripeptide Pro-Lys-Leu agrees with the consensus PTS1 sequence for two out of 
the three amino acids and it has previously been predicted as a possibly 
functional, though minor, PTS1 tripeptide (Reumann, 2004). In addition, it has 
been shown that both mammalian and plant Δ3,Δ 2 enoyl CoA isomerases, 
possessing the amino acid triplet –PKL at the C-terminus, are peroxisomal 
enzymes (Geisbrecht et al., 1999, Goepfert et al., 2008). In D.discoideum, it was 
found that this sequence acted as a PTS1 when the C-terminus of GFP was joined 
to the final 12 amino acid residues (VAIDMSHITPKLCOOH) of DdPMK.  
Furthermore, DdPMK from which the putative PTS1 (-PKL) was absent was no 
longer imported into the peroxisomes. Therefore, it is concluded that DdPMK, as 
well as DdHMGS(B), is a peroxisomal matrix enzyme.  
 
The cytosolic location of DdHMG-CoA synthase A and DdDPMD is not 
unexpected because neither of these enzymes possesses a PTS. Although it has 
been proposed that the mammalian HMG-CoA synthase localizes to the cytosol 
(Ayte et al., 1990), it  has also been claimed that it is a peroxisomal matrix protein 
that makes use of a sequence (SVX5QL) similar to a PTS2 (Olivier et al., 2000) to 
gain entry to the peroxisomes.This putative PTS2 is absent from the DdHMG-
CoA synthase A.  
ELNMNQTSAP 
(S/ A/ C) (K/R/H) (L/M) Consensus PTS1 
 
(R/K) (L/V/I) X5(H/Q) (L/A) Consensus PTS2 
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The cytosolic location of D.discoideum diphosphomevalonate decarboxylase 
conflicts with work by Simkin et al., (2011) on plants. They proposed that 
CrDPMD (C.roseus) and AtDPMD (A.thaliana) are localized to the peroxisomes. 
This may be due to the presence of a sequence resembling a putative PTS2 
(SVTLDP(A/D)HL) present in each enzyme around residue 40. In addition, 
Kovacs et al., (2007) postulated that mammalian DPMD is imported into the 
peroxisomes by a similar unusual PTS2 motif (SVX5QL). Nevertheless, other 
investigations have not confirmed that the mammalian DPMD is peroxisomal 
(Hogenboom et al., 2004a, Michihara et al., 2001). The cytosolic location for the 
DdDPMD is in agreement with the latter observations. Furthermore, the 
DdDPMD lacks the unusual PTS2 that has been proposed to allow the plant and 
mammalian DPMDs to enter the peroxisomes (Table3.2).   
Although two of the mevalonate pathway enzymes, mevalonate kinase and IDP-
isomerase, in D.discoideum appear to possess a PTS, neither PTS is functional. 
The putative PTS2 in D.discoideum mevalonate kinase, as in plant and 
mammalian mevalonate kinases, matches exactly the consensus PTS2 sequence 
but several observations, discussed previously, support the conclusion that this 
conserved sequence does not act as a PTS2.  Furthermore, the crystal structure of 
rat MVK revealed that the amino terminal lysine residue of the putative PTS2 is 
part of the ATP binding site (Fu et al., 2002). Therefore, despite the single 
investigation that identified a peroxisomal location for the mammalian MVK, it 
would appear that in D.discoideum and also in other organisms, the putative PTS2 
is not a functional peroxisomal targeting signal.  
By contrast, the putative PTS1 (-HRY) of D. discoideum IDP-isomerase matches 
only poorly the PTS1 consensus sequence. However, it has been shown that the 
hamster IDP-isomerase is directed into the peroxisomes by use of a similar 
sequence (-HRM) (Paton et al., 1997) and the second isozyme of human IDP-
isomerase (IDI2), containing a putative PTS1 (-HRV), has been identified as a 
peroxisomal enzyme (Paton et al., 1997, Clizbe et al., 2007).  Although the 
putative PTS1 in the DdIDP-isomerase is only slightly different from the 
mammalian PTS1s, it does not seem to direct the enzyme into the peroxisomes. 
However, there is no known example of any PTS1 ending in tyrosine and this 
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would support the conclusion that the DdIDP-isomerase is not a peroxisomal 
enzyme but is cytosolic.   
Finally, it has been shown previously that the final mevalonate pathway enzyme 
in D.discoideum, FDP-synthase, is peroxisomal. This enzyme has a slightly 
unusual PTS2 that directs it to the peroxisome (Nuttall et al., 2012). 
Taken together, the results presented in this chapter allow us to describe the 
intracellular locations of the mevalonate pathway enzymes in the same organism 
D.discoideum. However, the reasons for the distribution of the pathway enzymes 
between different cell compartments (i.e peroxisomes, cytosol and endoplasmic 
reticulum) are unclear. However, the intracellular location of the enzymes requires 
that all of the phosphorylated intermediates on the mevalonate pathway have to 
cross the peroxisomal membrane.  
The approach I used allowed us to identify proteins that can be imported into 
peroxisomes. Since these experiments were based on overexpression and tagging 
with fluorescent proteins, we can not exclude that the cytosolic localization 
observed in high expressing cells or in some of the fusions are due to the 
experimental set up or really reflect localization of these enzymes to the cytosol. 
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Chapter 4  
 
The initial steps of sterol biosynthesis in D. discoideum 
occur in the peroxisomes 
 
 
4.1 Introduction 
  
The enzymes catalyzing the reactions involved in sterol biosynthesis are 
associated with the endoplasmic reticulum (Nes, 2011). However, it was noticed 
that, Ddsqualene synthase, which catalyses the first unique step of sterol 
biosynthesis (Figure 4.1), possesses an apparent PTS1 (Ser-Lys-Leu COOH).  This 
sequence is also present in other species of slime mould such as Dictyostelium 
fasciculatum and Polysphondylium pallidum (Figure 4.2) but appears to be absent 
from squalene synthase enzymes in other groups of organisms. Moreover, two of 
the other enzymes catalyzing early steps of sterol biosynthesis in D.discoideum 
also possess a putative PTS1, i.e. oxidosqualene cyclase and cycloartenol-C-24-
methyltransferase (Figure 4.1). This suggested that the peroxisome may uniquely 
play an important role in the sterol biosynthetic pathway in D.discoideum.   
 
 
 
  
88 
 
 
 
Figure 4.1: Sterol biosynthesis in higher plants. This diagram shows a 
summary of the sterol biosynthesis pathway of higher plants. Multiple 
biosynthetic steps are indicated by broken arrows. In D.discoideum as in plants 
squalene is cyclised to form cycloartenol. 
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Figure 4.2: The deduced amino acid sequence of D. discoideum squalene 
synthase from related species of slime mould. (1) Polysphondylium pallidum 
(2) Dictyosteleum fasciculatum (3) Dictyostelium discoideum. These species have 
the same putative C-terminal PTS1 (-SKL).                                                                                                        
 As described in chapter 3, the approach using fusion proteins with GFP allowed 
us to detect successfully the intracellular locations of the mevalonate pathway 
enzymes in D.discoideum and this suggested that it might be possible to determine 
the intracellular location of the sterol biosynthesis enzymes by using the same 
technique. Therefore, in order to clarify the possible role of peroxisomes in the 
sterol biosynthetic pathway in D.discoideum, we decided to determine the 
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intracellular locations of the first five enzymes catalyzing sterol biosynthesis from 
farnesyl diphosphate.                                                                                                            
4.2   Results 
 
4.2.1   Squalene Synthase 
Squalene synthase (SQS) catalyses the first unique reaction of the biosynthesis of 
sterols by converting two molecules of farnesyl diphosphate into squalene. In 
addition, it has been shown that squalene synthase is generally localized to the 
endoplasmic reticulum.  For example, human and Arabidopsis thaliana squalene 
synthase were found to be targeted to the ER by a C-terminal hydrophobic 
transmembrane domain (Robinson et al., 1993, Busquets et al., 2008). 
Furthermore, Stamellos et al., (1993) postulated that the enzymatic activity of rat 
squalene synthase is localized to the ER. However, in D.discoideum the carboxy 
terminus of squalene synthase has a consensus PTS1 (-Ser-Lys-Leu).                                                                                          
We investigated the intracellular location of DdSQS by producing a GFP- DdSQS 
fusion protein so that the putative C-terminual PTS1 motif was not masked. The 
DNA fragment encoding the D.discoideum squalene synthase was amplified by 
PCR, using a proofreading enzyme (Velocity) and primers VIP 1892 and VIP 
1893, from the cDNA library. This fragment, encoding DdSQS, with the addition 
of the amino acids linker sequence Ser-Thr-Ser-Thr, was digested with BamHI  
and XbaI and ligated into BamHI-XbaI digested pDXA3C-MA to give pMA16. 
Amoebae transformed with pMA16 displayed a typical peroxisomal pattern of 
green fluorescence (Figure 4.3).  
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Figure 4.3: Analysis of squalene synthase in D.discoideum. The pattern of GFP 
fluorescence in amoebae expressing the GFP-DdSQS fusion protein was punctate. 
Scale bars 5µm.   
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A plasmid pMA15 was also constructed encoding mRFP-DdSQS. In amoebae co-
expressing mRFP-DdSQS (pMA15) and the peroxisomal marker pGFP-PTS1, the 
mRFP and GFP fluorescence overlapped (Figure 4.4). Thus, DdSQS is localized 
to the peroxisomes.                                                                                                                      
 
 
 
Figure 4.4: Demonstration of the peroxisomal localization of DdSQS. 
Amoebae were co-expressing mRFP-DdSQS and the peroxisomal marker pGFP-
PTS1. Co-localization of the mRFP and GFP fluorescence was observed in the 
peroxisomes. Scale bars 5µm.   
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4.2.2  mRFP-DdSQS is catalytically active                                       
In our laboratory, it had been previously found that over-expressing the fusion 
protein DdFDPS-GFP allowed D. discoideum amoebae to grow in the presence of 
a specific inhibititor of FDP-synthase (the NBP alendronate) at concentrations that 
would have totally inhibited growth of untransformed amoebae. Thus, it was 
concluded that the fusion protein is still catalytically active and it is able to fold 
properly into the active enzyme (Nuttall et al., 2012).                                                                                                                                                                                                                                                                                             
Similarly, attempts were made to determine whether transformants of D. 
discoideum amoebae expressing mRFP-DdSQS are resistant to BMS181221 
(Figure 4.5) which is a bisphosphonate that is a specific inhibitor of squalene 
synthase (Ciosek et al., 1993).                                                                                                                                
 
Figure 4.5: Structure of the bisphosphonate BMS181221 
D. discoideum amoebae overexpressing mRFP- DdSQS were initially selected in 
Blasticidin-containing medium before being transferred  to medium containing the 
bisphosphonate BMS181221 (4.3μM). Untransformed amoebae were also grown 
axenically either in the presence or absence of   BMS181221. Each culture (10ml) 
was inoculated with amoebae to an initial density of 1×10
4
 cells/ml and cell 
proliferation was assessed daily for a week by using a haemocytometer. Amoebae 
expressing the mRFP- DdSQS fusion protein were able to grow in the presence of 
BMS181221 whereas the untransformed amoebae failed to grow in the same 
conditions (Figure 4.6).                                                                                                                     
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Figure 4.6: Effects of BMS181221 on untransformed amoebae and amoebae 
transformed to express mRFP-DdSQS.  
In addition, analysis by fluorescent microscopy showed that mRFP-DdSQS was 
expressed at very high levels in amoebae that had been grown in medium 
containing BMS181221. However, the highly over-expressed fusion protein was 
still accumulated in the peroxisomes (Figure 4.7).   
 
 
  
 
 
 
 
Figure 4.7: Amoebae expressing mRFP-DdSQS become resistant to BMS 
181221.  (A) Amoebae transformed to express mRFP-DdSQS grown in the 
presence of 10µg/ml Blasticidin. (B) Amoebae transformed to express mRFP-
DdSQS grown in the presence of 4.3μM BMS181221. Scale bars 5µm.  
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Together, these results suggested that the fusion protein must have been 
catalytically active and able to fold into its native three dimensional structures. 
Furthermore, it shows that production of squalene in the peroxisomes promotes D. 
discoideum growth and this is consistent with the conclusion that squalene is also 
produced in untransformed amoebae in the peroxisomes.                                                                                                                                                                                                                                                                     
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4.2.3   Squalene Epoxidase 
 
The second reaction of sterol biosynthesis from squalene in which the squalene is 
converted into squalene epoxide is catalysed by squalene epoxidase. There have 
been few investigations of the intracellular location of squalene epoxidase. 
Krisans (1996) was unable to detect squalene epoxidase activity in purified 
peroxisomal fractions incubated with either squalene or dihydrolanosterol.  In 
addition, it has been reported that yeast squalene epoxidase encoded by ERG1 
gene, is localized to both the endoplasmic reticulum and lipid particles (Leber et 
al., 1998).                                                                                                                                             
 
In D. discoideum there is no obvious PTS sequence at either terminus of squalene 
epoxidase. However, because we had found that squalene synthase is peroxisomal 
enzyme we decided to determine the intracellular localization of squalene 
epoxidase by transforming amoebae to express a s.epoxidase-GFP fusion protein. 
The 1509bp DNA fragment encoding Ddsqualene epoxidase was amplified by 
PCR from the cDNA library by making use of VIP1309 and VIP 1310 primers. 
This DNA fragment also encoded the additional amino acid linker sequence Ser-
Thr-Ser-Thr at the C-terminus. It was digested with HindIII and BamHI and 
inserted into HindIII-BamHI digested pGFP, to obtain pMA17. There was a 
punctate pattern of GFP fluorescence, typical of a peroxisomal location, in 
amoebae transformed to express Dds.epoxidase-GFP (Figure 4.8).  
 
 
 
 
 
 
 
  
97 
 
 
 
 
 
Figure 4.8: Analysis of the expression s.epoxidase-GFP fusion protein in D. 
discoideum. Amoebae expressing Dds.epoxidase-GFP displayed a punctate 
pattern of green fluorescence. Scale bars 5µm. 
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When D.discoideum amoebae co-expressed pMA17 and the peroxisomal marker 
mRFP-PTS1, the two fluorescence signals coincided. This confirmed that 
Ddsqualene epoxidase is peroxisomal (Figure 4.9).     
                      
           
   
Figure 4.9: Squalene epoxidase is a peroxisomal enzyme in D. discoideum. In 
amoebae co-expressing Dds.epoxidase-GFP and the peroxisomal marker mRFP-
PTS1, the GFP and RFP fluorescence co-localised. Scale bars 5µm. 
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4.2.4   Oxidosqualene Cyclase (Cycloartenol synthase) 
Ddoxidosqualene cyclase (OSC), as in plants, converts oxidosqualene into 
cycloartenol. By contrast, in animals and fungi oxidosqualene cyclase produces a 
different sterol, lanosterol.  The C-terminus of D.discoideum oxidosqualene 
cyclase, as in other slime mould species, possesses a putative PTS1 (Figure 4.10). 
Several studies have shown that the C-terminal tripeptide –Ser-Lys-Ile, which is 
present on the DdOSC, can act as a PTS and therefore direct an enzyme into the 
peroxisomes (Recalcati et al., 2001, Purdue and Lazarow, 1994).                                                                    
 
 
Figure 4.10: Comparison of the amino acid sequences at the carboxy 
terminus of oxidosqualene cyclases from different slime moulds.                                                                     
 
There appear to have been few studies of the intracellular location of 
oxidosqualene cyclase. However, the human enzyme was purified for 
determination of its three-dimensional structure from the endoplasmic reticulum 
(Thoma et al., 2004).  
 
To determine the intracellular location of DdOSC, GFP- DdOSC and mRFP-
DdOSC fusion proteins were generated. The ORF of DdOSC was amplified by 
PCR from the cDNA library using primers VIP 1377 and VIP 1378. The 2112bp 
DNA fragment was digested with BamHI-EcoRI and ligated into digested p339-
3MA with BamHI-EcoRI to obtain pMA18 encoding mRFP-DdOSC. pMA19 
encoding  GFP- DdOSC was generated similarly. When  D.discoideum expressed 
either pMA18 or pMA19, a punctate fluorescence was observed (Figure 4.11).  
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Figure 4.11: Analysis of the expression of the GFP- DdOSC fusion protein in 
D.discoideum. Amoebae expressing GFP- DdOSC showed a punctate distribution 
of green fluorescence. Scale bars 5µm. 
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Furthermore, when amoebae co-expressed mRFP-DdOSC and the peroxisomal 
marker pGFP-PTS1 the punctuate fluorescence of GFP and mRFP overlapped and 
demonstrated that DdOSC is peroxisomal (Figure 4.12).   
                                                               
 
Figure 4.12: Demonstration of the peroxisomal location of DdOSC. Amoebae 
co-expressing mRFP-DdOSC and the peroxisomal marker pGFP-PTS1. Co-
localization of mRFP and GFP fluorescence was observed in the peroxisomes. 
Scale bars 5µm. 
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4.2.5  Cycloartenol -C-24-methyltransferase  
 
4.2.5.1   Cycloartenol -C-24-methyltransferase is localized to the peroxisomes 
                   
 
In plants, there are two families of sterol methyltransferases and it has been 
proposed that one family adds the first methyl group as the first step in 
cycloartenol modification. The second family adds a further methyl group, to give 
an ethyl group, near to the end of phytosterol synthesis (Bouvier-Nave et al., 
1998). By contrast, because ergosterol has only a single methyl group on C-24, 
S.cerevisiae adds only one methyl group to the C-24 of zymosterol and this is the 
last step of ergosterol synthesis. In mammalian cells, the transmethylation reaction 
is entirely absent because cholesterol lacks a C-24 methyl group. Since the major 
sterol in D.discoideum has a C-24 ethyl group, two families of transferases would 
be expected as in plants. There appear to be only two possible cycloartenol-C-24-
methyltransferases (SMT) in the D.discoideum genome and, since one has a 
putative PTS comprising the carboxy-terminal tripeptide  –Ala-Lys-Leu,  and 
cycloartenol is in the peroxisome, it seems probable that this enzyme catalyses the 
first methylation and the other enzyme catalyzed the second methylation to give 
an ethyl group. The putative PTS1 motif of cycloartenol -C-24-methyltransferases 
1 has also been conserved in the other slime mould species (Figure 4.13).                                                                          
 
 
 
Figure 4.13:  Comparison of the C-terminal amino acid sequences of the of 
cycloartenol -C-24-methyltransferases from different slime moulds.                                                                
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We investigated the intracellular location of DdSMT1 by generating a GFP-fusion 
protein. The 1389bp encoding DdSMT was amplified by PCR from the cDNA 
library using primers VIP 1453 and VIP 1454. The resultant DNA fragment, with 
the addition of a nucleotide sequence encoding an N-terminal linker sequence Ser-
Thr-Ser-Thr, was digested and ligated into BamHI-XbaI digested pDXA3C-MA 
to obtain pMA20. Wild type D.discoideum transformed with pMA20 encoding 
GFP-DdSMT1displayed a typical peroxisomal punctate pattern of GFP 
fluorescence (Figure 4.14).  
 
 
Figure 4.14: Analysis of the expression of the GFP-DdSMT1 fusion protein in 
D.discoideum. Amoebae expressing GFP-DdSMT1 displayed a punctate pattern 
of green fluorescence. Scale bars 5µm. 
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In addition, when amoebae co-expressed GFP-DdSMT1 together with the 
peroxisomal marker mRFP-PTS1, the fluorescence of the two proteins co-
localized, indicating that the Ddcycloartenol-C-24-methyltransferases 1 is 
peroxisomal (Figure 4.15).                                                                                                                                  
 
  
 
Figure 4.15: Cycloartenol-C-24-methyltransferases 1 is a peroxisomal 
enzyme in D.discoideum. Amoebae expressing both GFP-DdSMT1 and the 
peroxisomal marker mRFP-PTS1. Co-localization of mRFP and GFP fluorescence 
was observed in the peroxisomes. Scale bars 5µm. 
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4.2.5.2   Dd cycloartenol-C-24-methyltransferase 1 can complement yeast 
erg6  
 
Although DdSMT1 contains an amino acid sequence that is compatible with its 
being a sterol C-24 methyltransferase, it also has an N-terminal extension of 
approximately 114 amino acids (Figure 4.15). The role of the extension is 
unknown but its presence could indicate that the activity of DdSMT1 is no longer 
that of a cycloartenol -C-24- methyltransferase. Hence, the function of DdSMT1 
(Dictybase reference number DDB_G0275359) is not defined in Dictybase. It 
therefore appeared essential to determine whether the protein retains sterol 
methyltransferse activity.                                                                                                                                                    
 
The gene encoding D.discoideum cycloartenol-C-24-methyltransferase is 
homologous to Saccharomyces cerevisiae ERG6 (Figure 4.16). ERG6 is the 
structural gene that encodes the S.cerevisiae sterol-C-24-methyltransferase. This 
enzyme catalyzes addition of a single methyl group to zymosterol to give 
ergosterol.                                                                                                
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Figure 4.16: The deduced amino acid sequences of D. discoideum strain AX-2 
cycloartenol -C-24-methyltransferase 1 and S. cerevisiae ERG6 aligned using 
CLUSTALW.                                                                                        
  
An erg6∆ strain grows well in standard growth media but the permeability 
properties of the plasma membrane are changed and an erg6∆ strain can take up 
inhibitors to which the wild-type strain is impermeable. For example, an erg6∆ 
mutant strain exhibits cycloheximide sensitiviy and fails to grow on YNB  (Yeast 
Nitrogen Base) medium containing 0.05μg cycloheximide per ml (Gaber et al., 
1989). In order to determine DdSMT fusion protein can complement yeast erg6, 
two constructs were generated. The first construct (pMA22), generated by 
homologous recombination in yeast (section 2.2.5 in the Material and Methods 
Chapter), comprises pMA22 encoding cycloartenol-C-24-methyltransferase  
PTS1. The second construct pMA21 was also generated by homologous 
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recombination in yeast and encoded DdSMT1-GFP-PTS1. The erg6 mutant strain 
was transformed with either pMA21 or pMA22 and it was found that each 
transformed strain was able to grow in YPD medium containing 0.05 μg  per ml 
cycloheximide. It was also confirmed by fluorescence microscopy analysis that 
the fusion protein encoded by pMA22 was expressed in the cytosol whereas that 
encoded by pMA21 was peroxisomal (Figure 4.17).  
 
 
 
 
 
 
Figure 4.17: Analysis of the expression of Ddsterol methyl transferase in an 
erg6Δ strain of S. cerevisiae. (A) erg6∆ strain  expressing Ddsterol methyl 
transferase in the cytosol. The PTS1 had been removed. (B) erg6∆ strain  co-
expressing DdSMT1-GFP-PTS1 and  the peroxisomal marker HcRed-SKL. Scale 
bars 5µm.       
 
By contrast, the erg6 mutant strain transformed with the empty vector pEH116 
remained unable to grow in the cycloheximide-containing medium (Figure 4.18). 
Because expression of DdSMT1 allowed the erg6 mutant strain to grow like the 
wild-type strain in the presence of cycloheximide, it could be concluded that the 
transformed erg6 mutant was able to synthesise ergosterol and hence that 
DdSMT1 must have sterol-C-24-methyltransferase activity.                                                                                             
                         
(A) (B) 
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Figure 4.18: Demonstration that the pMA22 and pMA21 plasmids restore 
wild- type growth to an erg6 mutant of S.cerevisiae. Equivalent dilutions (0.1 
OD600) of overnight cultures were spotted on YPD, YM2 without uracil (YM2 
U¯) and YPD-cycloheximide medium. Since the WT was a S. cerevisiae 
(BY4742) ura¯ strain, it could not grow on a YM2 U¯plate. The erg6Δ strain of 
S.cerevisiae had been transformed with either the empty vector (pEH116) or 
pMA22 or PMA21. The plates were left for 2 days at 30ºC before being 
photographed.                                           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
119 
 
 
4.2.6   Methylsterol monooxygenase (Sterol 4α-methyl oxidase)  
In plants, it has been demonstrated that the two C-4 methyl groups are removed in 
separate steps by two different families of sterol 4α-methyl oxidase (SMO1 and 
SMO2) (Darnet and Rahier, 2004). In this context, it has been suggested that one 
family is responsible for the removal of the first methyl and the other family 
removes the second methyl group later.  Complete removal of each methyl group 
also needs a C-4 decarboxylase and sterone reductase.  In D.discoideum there are 
also two genes encoding methylsterol monooxygenases. The genes are adjacent 
on the chromosome and encode almost identical proteins. It appears as if they 
have arisen by a  recent gene duplication and it would seem probable that either 
enzyme can catalyse oxidation of the first and second methyl groups.  
In D.discoideum, neither of methylsterol monooxygenases has a PTS1 nor a 
PTS2, whereas the N-terminus of each monooxygenase comprises hydrophobic 
and charged amino acids which might act as ER-directed signal (Figure 4.19). 
This suggested that sterol biosynthesis will have moved from the peroxisomes to 
the ER. Therefore, it seems necessary to determine the intracellular location of the 
two monooxygenases.  
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Figure 4.19: The deduced amino acid sequences of D. discoideum strain AX-2 
methylsterol monooxygenase isoenzymes 1 and 2 aligned using CLUSTALW.                                                
 
We determined the intracellular location of both methylsterol monooxygenase by 
generating GFP-fusion proteins. Amoebae transformed with either pMA23 
encoding Ddmethylsterol monooxygenase (isozyme 1)–GFP or pMA24 encoding 
Ddmethylsterol monooxygenase (isozyme 2)–GFP had different patterns of GFP 
fluorescence from the typical peroxisomal pattern (Figure 4.20). This pattern 
suggested that the two fusion proteins are not peroxisomal but are localized to 
another cellular compartment which may be the endoplasmic reticulum. 
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Figure 4.20: Analysis of Ddmethylsterol monooxygenase (isozyme 1)–GFP 
expression in D. discoideum. Scale bars 5µm.       
 
 We therefore decided to re-transform the D.discoideum amoebae with two 
different endoplasmic reticulum markers to confirm the subcellular location of the 
Ddmethylsterol monooxygenases. The first marker was protein disulfide 
isomerase (PDI), a typical ER luminal marker (Monnat et al., 1997). The second 
maker was calnexin, which is a well- characterized protein in mammals.  It has 
been identified as an ER integral membrane calcium - binding  phosphoprotein  
(Bergeron et al., 1994).  Furthermore, it was used recently as a specific ER maker 
in amoebae of D.discoideum (Hervet et al., 2011).                                                                                
When D.discoideum amoebae co-expressing pMA23 with pMA25, encoding 
DdPDI- mRFP, or pMA26, encoding Ddcalnexin-mRFP, a complete co-
localization was obtained between the monooxygenase and calnexin (Figure 4.20 
A and B).   
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Figure 4.21 (A): The intracellular location of methylsterol monooxygenase 
isozyme (1) in D.discoideum. Amoebae co-expressing Ddmethylsterol 
monooxygenase (isozyme 1)–GFP and the ER marker DdPDI-mRFP. The Co-
localization of the fluorescence of both fusion proteins was partially observed. 
Scale bars 5µm.      
 
 
Figure 4.22 (B): The intracellular location of methylsterol monooxygenase 
isozyme (1) in D.discoideum. Amoebae co-expressing Ddmethylsterol 
monooxygenase (isozyme 1)–GFP and the ER marker Ddcalnexin-mRFP. Co-
localization of the GFP and mRFP fluorescence was observed. Scale bars 5µm.       
 
  
113 
 
A similar result was obtained with the second monooxygenase fusion protein 
(Figure 4.23) and Ddcalnexin-mRFP (Figure 4.24). Since both Ddmethylsterol 
monooxygenases co-localised with Ddcalnexin-mRFP and Ddmethylsterol 
monooxygenase (isozyme 1) only partially colocalised with DdPDI-mRFP it 
appeared probable that the monoxygenases are ER membrane proteins.  
 
Figure 4.23: Analysis of methylsterol monooxygenase (isozyme 2)–GFP 
expression in D. discoideum. Scale bars 5µm.       
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Figure 4.24: Demonstration of an ER localization of Ddmethylsterol 
monooxygenase (isozyme 2). Amoebae co-expressing Ddmethylsterol 
monooxygenase (isozyme 2)–GFP and the ER marker Ddcalnexin-mRFP. Co-
localization of the GFP and mRFP fluorescence was observed. Scale bars 5µm.       
 
 
 
 
 
 
 
 
 
 
 
 
 
  
115 
 
4.3   Discussion 
 Whereas in other organisms the first four steps on the pathway converting 
farnesyl diphosphate to sterols are catalyzed by enzymes associated with the 
endoplasmic reticulum, our data demonstrate that these steps in D.discoideum take 
place in the peroxisomes (Table 4.1).                                     
 
Table 4.1: The intracellular locations of six sterol biosynthesis enzymes in 
Dictyostelium discoideum based on fusion proteins studies.                                                                                                                                  
Enzyme 
location 
Putative 
PTS 
C-terminal 
sequence 
N-terminal 
sequence 
Enzyme 
Peroxisome PTS1 GPNFFSKL MQYMKSLAHPD
EFLSLLKIGYTES
FKPKSQ 
DdSQS 
Peroxisome No PTS NICIILRLTK MEDIQFENEVDN
KVFDIIVVGAGV
AGSAFA  
DdS.epoxidase 
Peroxisome PTS1 YNQLYLKSKI MTTTNWSLKV 
DRGRQTWEYS 
QEKKEATDVD 
DdOSC 
Peroxisome PTS1 LSSKPNAAKL MVLIQTNHQ 
SKPIEINQSA 
EKVIAFLLDV  
DdSMT 
ER No PTS IEKKSINKSE MESLSLKFIEPY
WFKFVDYYGEE
FLLTYGT 
DdMSMA 
 
ER No PTS DSKLAAGKSE MESLSLKFIEPY
WFKFVDYYGED
FLITYGT 
DdMSMB 
 
 (S/ A/ C) (K/R/H) (L/M)  C  Consensus PTS1 
Consensus PTS2                      (R/K) (L/V/I) X5(H/Q) (L/A) 
  
116 
 
Four of the sterol biosynthetic pathway enzymes are peroxisomal but only three 
have an obvious PTS1 (Table 4.1). Squalene synthase possesses the most 
sufficient PTS1 (-SKLCOOH) at its C-terminus and the C-terminal triplet of amino 
acids (-AKLCOOH ) in cycloartenol-C-24-methyltransferase is known to be an 
effective PTS1. Similarly, the C-terminal sequence of oxidosqualene synthase (-
SKICOOH) has been previously shown to be a functional PTS1 (Recalcati et al., 
2001, Purdue and Lazarow, 1994).                                                              
Although D.discoideum squalene epoxidase was shown to be peroxisomal, it 
appears not to possess a PTS and the mechanism by which it enters the 
peroxisome is not clear. Therefore, the process by which the Ddsqualene 
epoxidase is imported into the perxisomes requires further investigation. 
However, it has been suggested that some peroxisomal proteins lacking a PTS 
may be imported into the perxisomes by using a third type of targeting sequence 
that has not been identified (van der Klei and Veenhuis, 2006). In addition, other 
studies have also indicated that some peroxisomal matrix proteins are able to enter 
the peroxisome, despite lacking a PTS, by still being able to bind to Pex5 or by a 
piggy-backing process by which the protein binds to another protein containing a 
PTS sequence (Islinger et al., 2009, Klein et al., 2002).      
By contrast, enzymes catalyzing later steps i.e. from the methylsterol 
monooxygenase onwards appear, as in other organisms, to be associated with the 
endoplasmic reticulum. These enzymes seem to have an ER- directed signal and 
do not seem to have a PTS.                                                                                      
Overall, our data showed that the peroxisomes have an important role in the sterol 
biosynthetic pathway in D.discoideum since there are four enzymes of the 
pathway associated with the peroxisomes.  However, no previous studies have 
detected a peroxisomal location of the sterol biosynthesis enzymes in other 
organisms. Thus, it seems that a role of the peroxisomes in sterol biosynthesis is a 
unique aspect in D.discoideum.                                                                                                              
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Chapter 5  
Membrane association of the peroxisomal enzymes 
involved in sterol biosynthesis in D. discoideum   
 
5.1 Introduction 
Peroxisomal membrane proteins (PMPs) and matrix proteins require different 
factors for their targeting and insertion into or translocation across the 
peroxisomal membrane. Matrix protein import relies on the well-characterised 
peroxisomal targeting signal type 1 or type 2. These PTSs are absent from PMPs, 
which contain poorly defined sequences that mediate peroxisomal targeting. Two 
classes of PMPs can be distinguished. Class1 PMPs traffic via the ER to 
peroxisomes whereas Class2 PMPs are directly inserted into the peroxisomal 
membrane dependent on Pex3 and Pex19. 
The data presented in chapter 4 demonstrate clearly that four of the sterol 
biosynthesis enzymes in D.discoideum are localized to the peroxisomes. Three of 
these enzymes seem to have a clear PTS1. However, for instance Ddsqualene 
synthase also possesses a predicted transmembrane domain located near to its C-
terminus, which appears to resemble the transmembrane domain of A.thaliana and 
human squalene synthases (Table 5.1) that are responsible of anchoring these 
enzymes into the ER membrane (Jennings et al., 1991, Robinson et al., 1993, 
Busquets et al., 2008). In addition, cycloartenol synthase contains a putative PTS1 
and a predicted transmembrane segments (Table 5.2). Squalene epoxidase and 
cycloartenol-C-24-methyltransferase contain a transmembrane segment or a 
PTS1, respectively (Table 5.2). It therefore appeared important to investigate 
whether Ddsqualene synthase and other sterol biosynthesis enzymes are 
associated with the peroxisomal membrane. 
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Organism 
 
The predicted C-terminal TM Position Uniprot 
number 
Length 
D. discoidium 
 
FISYDWMAVTSLAVSSAFLIA 386-406 Q54DR1 21 
A.thaliana QPNSVFIIMVVILLAIVFAYL 387-407 P53799 21 
S.cerevisiae FNMVLSIILSVLLGFYYIYTL 421-441 P29704 21 
 
H.sapiens 
 
 PIYLSFVMLLAALSWQYLTTL 
 
384-404 
 
P37268 
 
21 
 
Table 5.1: Predicted transmembrane domains of squalene synthase from 
different organisms as predicted by Uniprot.  
 
 
Table 5.2: Predicted transmembrane domains and the putative PTS1 of  the 
four sterol biosynthesis enzymes in D.discoideum. 
 
To investigate the possible membrane association of the four D. discoideum sterol 
biosynthesis enzymes, two biochemical methods were used. First, disrupted 
amoebae were divided into soluble and insoluble fractions by centrifugation. The 
insoluble fraction was extracted with 1M NaCl at 0ºC for 30 min in order to 
remove any protein that associated with the membrane by non-specific ionic 
interactions. Furthermore, Na2CO3  pH 11.4 at 0ºC treatment was used on a second 
sample of the insoluble fraction to distinguish between the peripheral and integral 
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membrane proteins (Fujiki et al., 1982, Elgersma et al., 1997). Only peripheral 
membrane proteins are released by this treatment whereas integral membrane 
proteins remain embedded wihin the membrane. 
 
The aim of this chapter is therefore to describe investigations of the membrane 
association of squalene synthase and the other sterol biosynthesis enzymes 
because it would be unusual for a peroxisomal matrix protein to be associated 
with the membrane.  
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5.2 Results 
 
5.2.1 Control conditions 
 
Amoebae transformed with either pGFP-PTS1 or pMA23 encoding 
Ddmethylsterol monooxygenase-GFP were disrupted and the insoluble fractions 
were treated with 1M NaCl or 100mM carbonate pH 11.4 respectively (section 
2.9.3 Materials and Methods). GFP-PTS1 was used as a control for a peroxisomal 
matrix protein and it was found that most of the GFP was released immediately 
into the soluble fraction from amoebae disrupted by sonication (Figure 5.1 A) 
whereas Ddmethylsterol monooxygenase, used as control for an integral 
membrane protein, was, as expected, not extracted by Na2CO3 pH 11.4 (Figure 5.1 
B).  
 
 
    
 
 
Figure 5.1: Control conditions.  (A) Amoebae transformed with pGFP-PTS1 
were disrupted by sonication and the insoluble fraction was treated with 1M NaCl 
followed by high speed centrifugation ~ 233,000 gmax. (B) Amoebae transformed 
with Ddmethylsterol monooxygenase 1-GFP were disrupted and the insoluble 
fraction was treated with 100mM sodium carbonate pH 11.4 followed by high 
speed centrifugation ~ 233,000 gmax. Each sample on the immunoblot was derived 
from approximately the same number of cells. Total (the whole lysate), First s (the 
supernatant after the first centrifugation), Pellet (the insoluble fraction after 1M 
NaCl or 100mM Na2CO3 pH 11.4 treatment), Final s (the supernatant after 1M 
NaCl or  100mM Na2CO3 pH 11.4  treatment). 
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5.2.2 Squalene synthase is tightly bound to the peroxisomal membrane  
 
Although the Ddsqualene synthase possesses the most efficient PTS1 (-SKL) 
there is a predicted trans-membrane domain (TM) located near to the C-terminus 
(Table 5.1) of this enzyme which implies that Ddsqualene synthase might be 
associated with the peroxisomal membrane. We therefore, decided to investigate 
the membrane association of Ddsqualene synthase by using biochemical methods. 
Membrane fractions from amoebae expressing DdGFP-SQS were treated with 1M 
NaCl followed by high speed centrifugation ~233,000 gmax (section 2.9.4 
Materials and Methods) in order to release any peripheral membrane proteins. It 
was found that Ddsqualene synthase remained in the pellet fraction suggesting 
that this enzyme is strongly associated with the peroxisomal membrane (Figure 
5.2 A). Furthermore, we found that Ddsqualene synthase was not extracted with 
100mM Na2CO3 pH 11.4 (section 2.9.3 Materials and Methods) (Figure 5.2 B). 
Together, these results suggested that Ddsqualene synthase is tightly bound to the 
peroxisomal membrane and that it behaves like an integral membrane protein. 
 
 
 
 
 
 
Figure 5.2: Association of D. discoideum squalene synthase with the 
peroxisomal membrane. (A) 1M NaCl treatment. (B) 100mM sodium carbonate 
pH 11.4 treatment. Amoebal homogenate  was centrifuged at 4 ˚C for 1 hour at 
50,000 rpm using a Beckman 50 Ti rotor. The supernatant (First s) was separated 
from the pellet and subjected to SDS- PAGE and western blot analysis using an 
anti-GFP antibody. The pellet fraction was extracted with either 1M NaCl or 
100mM Na2CO3 pH 11.4. Extracted proteins were separated from the membranes 
by high speed centrifugation. Samples of the pellet and supernatant fractions were 
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analyzed by immunoblot analyses using the anti-GFP antibody. Each sample on 
the immunoblot was derived approximately from the same number of cells. Total 
(the whole lysate), First s (the supernatant after the first centrifugation), Pellet (the 
insoluble fraction after 1M NaCl or 100mM Na2CO3 pH 11.4 treatment), Final s 
(the supernatant after 1M NaCl or  100mM Na2CO3 pH 11.4  treatment). 
 
5.2.3 Squalene epoxidase is associated with the peroxisomal membrane 
Analysis of the hydrophobicity plot (Krogh et al., 2001) Ddsqualene epoxidase 
indicated that the enzyme possessess a highly hydrophobic C-terminal sequence 
(amino acid residues 439 to 456) (Figure 5.3). In addition, the N-terminus 
contains a less hydrophobic sequence extending from residues 15 to 33. This led 
to the hypothesis that squalene epoxidase might be associated with the 
peroxisomal membrane.  
 
 
 
Figure 5.3: Hydropathy plot of Ddsqualene epoxidase using TMHMM 
(www.cbs.dtu.dk/services/TMHMM). The red columns indicate the predicted 
transmembrane domains. 
 
In order to investigate the membrane association of Ddsqualene epoxidase we 
applied both treatments, 1M NaCl and 100mM Na2CO3 pH11.4 (section 2.9.3 and 
2.9.4 Materials and Methods), to the insoluble fractions from amoebae 
overexpressing Ddsqualene epoxidase-GFP. Ddsqualene epoxidase was not 
removed by 1M NaCl suggesting that this enzyme is strongly associated with the 
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peroxisomal membrane and therefore is not a peripheral membrane protein 
(Figure 5.4 A). By contrast, Ddsqualene epoxidase was removed after extraction 
with 100mM Na2CO3 pH11.4 (Figure 5.4 B). Thus, Ddsqualene epoxidase is 
strongly associated with the peroxisomal membrane but it is not an integral 
membrane protein. 
 
 
 
 
 
Figure 5.4: Association of D. discoideum squalene epoxidase with the 
peroxisomal membrane. (A) 1M NaCl treatment. (B) 100mM sodium carbonate 
pH 11.4 treatment. Further details are given in the legend to Figure 5.2. Total (the 
whole lysate), First s (the supernatant after the first centrifugation), Pellet (the 
insoluble fraction after 1M NaCl or  100mM Na2CO3 pH 11.4 treatment), Final s 
(the supernatant after 1M NaCl or  100mM Na2CO3 pH 11.4  treatment). 
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5.2.4 Oxidosqualene cyclase (Cycloartenol synthase) is associated with the 
peroxisomal membrane  
Previously, we determined the intracellular location of D. discoideum 
oxidosqualene cyclase which was found to be peroxisomal. In addition, in this 
chapter we showed that two of the sterol biosynthesis enzymes are associated with 
the peroxisomal membrane (i.e. squalene synthase and squalene epoxidase). On 
the basis of these results, it seemed probable that DdOSC would also be 
associated with the peroxisomal membrane because the product of the enzyme-
catalysed reaction is highly hydrophobic and therefore must be released 
temporarily into a membrane prior to the subsequent methylation reaction.  
 
To investigate the membrane association of D. discoideum oxidosqualene cyclase 
the insoluble fraction obtained from disrupted amoebae was treated with either 
1M NaCl or 100mM Na2CO3 pH11.4. We found that GFP-DdOSC was not 
removed by 1M NaCl suggesting that the enzyme is strongly bound to the 
peroxisomal membrane (Figure 5.5 A). By contrast, when the pellet fraction was 
treated with carbonate approximately half of the protein remained in the pellet 
fraction while 50% of the protein was released in the supernatant (Figure 5.5 B). 
Thus, these results indicated that Ddoxidosqualene cyclase is strongly associated 
with the peroxisomal membrane. 
 
Figure 5.5:  Biochemical analysis of D. discoideum oxidosqualene cyclase. (A) 
1M NaCl treatment. (B) 100mM sodium carbonate pH 11.4 treatment. Further 
details are given in the legend to Figure 5.2. Total (the whole lysate), First s (the 
supernatant after the first centrifugation), Pellet (the insoluble fraction after 1M 
NaCl or 100mM Na2CO3 pH 11.4 treatment), Final s (the supernatant after 1M 
NaCl or  100mM Na2CO3 pH 11.4  treatment). 
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5.2.5 Cycloartenol-C-24-methyltransferase is tightly bound to the 
peroxisomal membrane                                                                                                                               
It appeared that, because the first three enzymes of sterol biosynthesis from 
farnesyl diphosphate are associated with the peroxisomal membrane, it was 
necessary to determine whether the next enzyme was also peroxisomal membrane 
protein. Therefore, in experiments intended to investigate whether 
Ddcycloartenol-C-24-methyltransferase is also associated with the peroxisomal 
membrane, we treated the pellet fraction from amoebae that overexpressd DdSMT 
with Na2CO3 pH 11.4. It was found that DdSMT cannot be extracted by carbonate 
at pH 11.4 (Figure 5.6), suggesting that Ddcycloartenol-C-24-methyltransferase is 
tightly bound to the peroxisomal membrane and behaves like an integral 
membrane protein.    
     
 
 
Figure 5.6: Association of D. discoideum cycloartenol-C-24-methyltransferase 
with the peroxisomal membrane. Amoebae were treated with 100mM sodium 
carbonate pH 11.4. Total (the whole lysate), First s (the supernatant after the first 
centrifugation), Pellet (the insoluble fraction after the carbonate treatment), Final s 
(the supernatant after the carbonate treatment). 
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5.2.6 Is the PTS1 on squalene synthase, oxidosqualene cyclase and 
cycloartenol -C-24-methyltransferase functional? 
By definition, peroxisomal matrix proteins do not associate with the peroxisomal 
membrane. Furthermore, proteins with a PTS1 are believed to be matrix proteins 
and thus not to be membrane proteins. Peroxisomal membrane proteins (PMPs) 
require an entirely different pathway for their sorting into the peroxisomes 
(Pex19p and Pex3p pathways). Therefore, it seemed necessary to test whether the 
putative PTS1 of Ddsqualene synthase, Ddoxidosqualene cyclase and DdC-24-
methyltransferase is involved in peroxisomal import because these appear to be 
membrane-associated proteins rather than matrix proteins.                                                                                                           
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5.2.7 Squalene synthase  
A PCR product encoding Ddsqualene synthase, lacking the last three amino acids 
comprising the PTS1 (-Ser-Lys-LueCOOH), was generated using pMA16 as a DNA 
template and VIP1892 plus VIP2184 as primers. This cDNA fragment was 
digested with BamHI and XbaI and ligated into BamHI – XbaI digested 
pDXA3C-MA to obtain pMA27. When amoebae expressed pMA27 encoding 
GFP-DdSQSΔPTS1 a punctate distribution of fluorescence was mainly observed 
in addition to some cytosolic background (Figure 5.7). 
 
 
 
Figure 5.7: Analysis of GFP-DdSQSΔPTS1 expression in D. discoideum.  
Amoebae expressing GFP-DdSQSΔPTS1exhibited an apparently typical 
peroxisomal pattern of green fluorescence in addition to some cytosolic 
fluorescence distribution. Scale bars 5μm. 
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Amoebae expressing pMA27 were re-transformed to express the peroxisomal 
marker mRFP-PTS1 in order to investigate whether the punctate fluorescence was 
peroxisomal. It was found that GFP-DdSQSΔPTS1, despite the absence of the 
PTS1, co-localized with the peroxisomal marker was partially observed (Figure 
5.8).  
 
 
 
 
 
Figure 5.8: The intracellular localization of GFP-DdSQSΔPTS1 in D. 
discoideum. Amoebae co-expressing GFP-DdSQSΔPTS1 and the peroxisomal 
marker mRFP-PTS1. The co-localization of the GFP and mRFP fluorescence was 
partially observed in the peroxisomes. Scale bars 5μm. 
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5.2.8 Oxidosqualene cyclase  
 
To determine whether the putative PTS1 (-SKICOOH) of Ddoxidosqualene cyclase 
is responsible for the peroxisomal localization, a truncated version of DdOSC, 
encoded by pMA28, lacking the putative PTS1 was expressed in amoebae. When 
D. discoideum amoebae expressed pMA28, encoding GFP-DdOSCΔPTS1, the 
fusion protein was mislocalized to the cytosol where it was associated with 
unusual structures (Figure 5.9). This suggested that DdOSC PTS1 is responsible 
of targeting the enzyme into the peroxisomes. 
 
 
Figure 5.9: Analysis of GFP-DdOSCΔPTS1 expression in D. discoideum. The 
GFP fluorescence appeared to be associated with components of the cytosol. Scale 
bars 5μm.   
 
 
 
 
 
  
131 
 
 
Further experiments were carried out in order to investigate the possible 
intracellular location of DdOSC-ΔPTS1. D. discoideum amoebae were therefore 
re-transformed either with pMA26 encoding DdCalnexin-mRFP (ER membrane 
marker) or pMA30 encoding DdTop2-isomerase-mRFP (mitochondrial marker). 
When amoebae were co-expressing GFP-DdOSC-ΔPTS1and DdCalnexin-mRFP, 
the fluorescence of the GFP partially co-localized with the mRFP fluorescence 
(Figure 5.10). In addition, in some cells, there was a ring of GFP fluorescence 
coinciding with the plasma membrane (Figure 5.10). 
 
 
 
Figure 5.10: Association of GFP-DdOSC-ΔPTS1 with the ER membrane. 
Amoebae expressing both GFP-DdOSC-ΔPTS1 and an ER marker (DdCalnexin-
mRFP). Co-localization of the GFP and mRFP fluorescence was observed in the 
ER. Scale bars 5μm.  
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Furthermore, when amoebae were co-expressing GFP-DdOSC-ΔPTS1 and 
DdTop2-isomerase-mRFP, the fluorescence patterns of GFP and mRFP partially 
superimposed (Figure 5.11).   
 
 
 
 
Figure 5.11: Association of GFP-DdOSC-ΔPTS1 with the mitochondria. 
Amoebae co-expressing GFP-DdOSC-ΔPTS1 and DdTop2-isomerase-mRFP 
(mitochondrial marker). Co-localization of GFP and mRFP fluorescence was 
observed around the mitochondria. Scale bars 5μm.  
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5.2.9 Cycloartenol -C-24-methyltransferase  
 
In order to investigate whether the putative PTS1 (-AKL) of Ddcycloartenol-C-
24-methyltransferase targets the enzyme to the peroxiomes, a GFP-DdSMT minus 
PTS1 construct (pMA29) was generated. In amoebae expressing pMA29, 
encoding GFP-DdSMTΔPTS1, the fusion protein accumulated entirely in the 
cytosol (Figure 5.12). Thus, this result indicated that the putative PTS1 is essential 
for the peroxisomal localization of Ddcycloartenol-C-24-methyltransferase. 
` 
 
 
 
Figure 5.12: Analysis of GFP-DdSMTΔPTS1 expression in D. discoideum. 
Amoebae expressing GFP- DdSMTΔPTS1 showed green fluorescence only in the 
cytosol. Scale bars 5μm. 
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5.3 Discussion 
The biochemical approaches making use of 1M NaCl and 100mM carbonate 
extraction of the membrane-containing fraction from amoebae, demonstrated that 
the first four enzymes involved in converting farnesyl diphosphate into sterols in 
D. discoideum are associated with the peroxisoml membrane. Squalene synthase 
and cycloartenol-C-24-methyltransferase are tightly bound to the peroxisomal 
membrane and seem to behave as integral membrane proteins. Oxidosqualene 
cyclase was partially extracted by 100mM carbonate whereas squalene epoxidase 
was not extracted by high salt treatment but it was released completely into the 
supernatant by the carbonate. It appeared that these two enzymes cannot be 
transmembrane membrane proteins although they must, nevertheless, be tightly 
bound to the peroxisomal membrane.                                                                                                                                  
Treatment with 100mM carbonate revealed that Ddsqualene synthase behaves as 
an integral membrane protein. The C-terminal hydrophobic sequence of human, 
yeast and A. thaliana squalene synthase contains a predicted trans-membrane 
domain (Jennings et al., 1991, Robinson et al., 1993, Kribii et al., 1997, Busquets 
et al., 2008). This sequence plays an important role in anchoring squalene 
synthase into the ER membrane. Furthermore, the bioinformatic predication for 
trans-membrane domains (TM) suggests the existence of a similar TM domain in 
the Ddsqualene synthase which is again located very close to the carboxy 
terminus. This evidence suggests that Ddsqualene synthase may be tail-anchored 
into the peroxisomal mermbrane. 
 
Although the bioinformatic data support the presence of the trans-membrane 
domain at the C-terminus of Ddsqualene epoxidase, our results suggested that this 
protein does not act as an integral membrane protein. The mechanism by which 
the Ddsqualene epoxidase becomes asssociated with the peroxisomal membrane 
remains unclear.   It is also unclear how the epoxidase enters the peroxisomes 
because it lacks a PTS. 
 
Ddoxidosqualene cyclase (cycloartenol synthase) is associated with the peroxisomal 
membrane but it is not tightly bound. In addition, it has been postulated that the 
human lanosterol synthase (oxidosqualene cyclase) is a monotopic integral 
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membrane protein (Figure 5.13) (Thoma et al., 2004, Ruf et al., 2004). 
Furthermore, it was found that there is a predicted amphipathic membrane anchor 
helix in Ddoxidosqualene cyclase that corresponds to the membrane anchor helix 
of human lanosterol synthase (Figure 5.14). X-ray crystal structure analysis 
demonstrated that squalene-hopene cyclase, homologous to the eukaryotic OSC, 
from the bacterium Alicyclobacillus acidocaldarius is integrated partially into the 
membrane (Wendt et al., 1997, Bracey et al., 2004, Siedenburg and Jendrossek, 
2011). Therefore, the membrane association of Ddoxidosqualene cyclase might be 
classified as a monotopic membrane protein (a protein that inserts within one 
leaflet of the membrane bilayer but does not span the membrane).    
  
 
 
 
Figure 5.13: Three dimensional structure of human lanosterol synthase. The 
predicted membrane anchor helix is shown in red. This image was kindly 
provided by Dr Patrick Baker and is derived from the structure elucidated by 
Thoma et al, (2004).   
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Figure 5.14: Predicted membrane anchor helix of human lanosterol synthase (A)  
and  D. discoideum cycloartenol synthase(B). It seems that a similar helix is 
present in Ddcycloartenol synthase. These structures were kindly provided by Dr 
Patrick Baker.  
 
Previous studies have suggested that the import of peroxisomal matrix proteins 
and the insertion of peroxisomal membrane proteins occur by two independent 
pathways (Erdmann and Blobel, 1996, Gould et al, 1996). In addition, it has been 
postulated that the PTS1 and PTS2 pathways are responsible for the entry of the 
peroxisomal matrix protein but not the membrane proteins. It remains unclear how 
at least oxidosqualene cyclase and cycloartenol-C-24-methyltransferase 
apparently behave as peroxisomal matrix proteins but also associate with the 
peroxisomal membrane. 
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Chapter 6 
General discussion and Future directions 
 
The initial aim of this study was to determine the intracellular 
compartmentalization of the mevalonate pathway enzymes in Dictyostelium 
discoideum. The evidence presented, based upon generating fusion proteins, 
demonstrates that three enzymes of the pathway are localized to the peroxisomes: 
the second isozyme of HMG-CoA synthase, phosphomevalonate kinase and 
farnesyl diphosphate synthase. The latter had been identified previously as a 
peroxisomal enzyme in D.discoideum (Nuttall et al., 2012). HMG-CoA reductase, 
as in other organisms, is localized to the ER whereas four enzymes of the MVA 
pathway are cytosolic.                                                          
It has been shown in mammals that the peroxisomal membrane is permeable to  
small  molecules whereas it does not allow uptake of large molecules such as the 
cofactors NAD/H, NADP/H and phosphorylated components by simple diffusion 
(Antonenkov et al., 2004b). Due to the compartmentalization of the D.discoideum 
MVA pathway into three cellular compartments: perosixsome, cytosol and ER, all 
of the pathway phosphorylated intermediates need to cross the peroxisomal 
membrane: phosphomevalonate, isopentenyl diphosphate and dimethylallyl 
diphosphate must have to immigrate from the cytosol into the peroxisomes. 
However, some of the phosphorylated components need to travel in the opposite 
direction such as diphosphomevalonate and farnesyl diphosphate (Figure 1.6). In 
S.cerevisiae, it has been proposed that the passage of the phosphorylated 
compound ADP from the cytosol into the peroxisomal matrix requires a specific 
transport system (Palmieri et al., 2001, Lasorsa et al., 2004). This implies that the 
shuttle of MVA pathway phosphorylated compounds across the peroxisomal 
membrane will also require a transport system although this has yet to be 
identified.   
Although there is evidence that most of the mammalian MVA pathway enzymes 
are peroxisomal (reviewed by Kovacs et al, 2007), the localization of the pathway 
enzymes in D.discoideum is only partially consistent with the mammalian 
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distribution proposed by Kovacs et al, (2007). As in D.discoideum, it has been 
shown previously in mammals that the second isozyme of HMG-CoA synthase, 
phosphomevalonate kinase and FDP-synthase are localized to the peroxisomes 
(Olivier et al., 2000, Kovacs et al., 2007). Indeed, the peroxisomal location of the 
D.discoideum enzymes is consistent with the presence of strong PTS sequences. 
By contrast, D.discoideum isopentenyl diphosphate isomerase was found to be 
localized to the cytosol wherease the two isozymes of human IDP- isomease were 
identified as peroxisomal enzymes (Clizbe et al., 2007). This peroxisomal 
targeting is facilitated by unusual tripeptide combinations which each seem to act 
as a functional PTS1. However, much evidence (discussed previously in Chapter 
3) supports the conclusion that the amino acid triplet at the C-terminus of  
D.discoideum IDP-isomerase does not act as a PTS1.  Furthermore, our data 
support a cytosolic location of both mevalonate kinase  and diphosphomevalonate 
decarboxylase as described by (Hogenboom et al., 2004b, Hogenboom et al., 
2004a) for mammalian cells.  Nevertheless, Krisans’ group appears to have 
demonstrated a peroxisomal location for mevalonate kinase and the decarboxylase 
in mammals (Kovacs et al., 2007).                                                                                                  
Investigations of the intracellular locations of the mevalonate pathway in 
mammals mainly rely on subcellular fractionation and immunofluorescence 
microscopy studies. Use of the subcellular fraction method requires great care 
because the peroxiomal membrane is known to be fragile. Furthermore, it has 
been reported that some of the peroxisomal matrix protein can seep out easily 
from the peroxisome during the fractionation (Antonenkov et al., 2004b, 
Antonenkov et al., 2004a)  which may lead to misinterpretation of the enzyme 
subcellular location. One limitation of using immunofluorescence microscopy is 
that the antibody may be able to detect its antigen only when the antigen is at a 
higher concentration than is usually present in cells. Therefore, the antibody 
cannot recognize its target in the cytosol. The limitations of the subcellular 
fractions and immunofluorescence microscopy approaches discussed above may 
explain the conflicting results that have been reported on the role of peroxisomes 
in the mammalian mevalonate pathway.       
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In plants, the experimental data regarding the intracellular compartmentalization 
of the MVA pathway is very limited. However, as in D.discoideum, it has been 
demonstrated that plant mevalonate kinase is a cytosolic enzyme and 
phosphomevalonate kinase have been identified as a peroxisomal enzyme (Simkin 
et al., 2011). By contrast, the cytosolic location of both D.discoideum 
diphosphomevalonate decarboxylase and IDP-isomerase  does not agree with the 
data from  plants  system which apparently support a peroxisomal  location  for 
each enzyme (Sapir-Mir et al., 2008, Simkin et al., 2011).                                                                                                                                     
Based upon the data and the arguments presented above a new model describing 
the compartmentalization of the MVA pathway in the unicellular organism 
D.discoideum can be proposed (Figure 1.6). This model provides a clear picture, 
at least in one organism, as to where each substrate must be present to allow each 
enzyme reaction to occur. Nevertheless, the reason for distribution of the MVA 
pathway enzymes between the three cellular compartments has not been 
identified.                                                                       
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Figure 6.1:  A current view of the intracellular locations of the mevalonate 
pathway enzymes in the unicellular organism Dictyostelium discoideum.         
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The successful used of the fusion protein approach to investigate the intracellular 
location of the MVA pathway encourages us to characterize the intracellular 
compartmentalization of the following pathway (sterol biosynthesis) because it 
appeared that, unusually, the first enzyme on this pathway has a PTS1 in D. 
discoideum. A further aim of this study was therefore, to investigate the 
intracellular locations of the first five enzymes involved in converting farnesyl 
diphosphate to sterol in D. discoideum. The peroxisomal location of the first four 
enzymes of sterol biosynthesis is uniquely observed in the slime mold D. 
discoideum. Three of the pathway enzymes in D. discoideum possess a putative 
PTS1 and these have been identified as peroxisomal proteins:  squalene synthase, 
oxidosqualene cyclase and cycloartenol -C-24-methyltransferase. Despite lacking 
a PTS, Ddsqualene epoxidase, which catalyzes the second reaction of the sterol 
biosynthesis, was also found in the peroxisomes.  Nevertheless, the two isozymes 
of the methylsterol monooxygenase are associated with the endoplasmic 
reticulum. Therefore, one would expect that the enzymes catalyzing the later steps 
of the sterol biosynthetic pathway in D. discoideum will be localized as in other 
organisms to the ER, because these enzymes seem to possess an ER-directed 
signal but do not possess a PTS. The reasons for the enzymes’ distribution 
between the two cellular compartments: peroxisomes and ER is not clear. In 
addition, it is assumed that there is a mechanism by which the intermediate C-24 
methylcycloartenol is transferred from the peroxisomes to the ER. Different 
mechanisms can be envisaged including vesicular transport, lipid transfer protein 
mediated transport or diffusion via membrane continuations or contact sites. The 
mechanism has yet to be elucidated.                                                                       
Furthermore, another unique aspect of the sterol biosynthesis enzymes in D. 
discoideum is that although the first four enzymes appear to enter the peroxisome 
as peroxisomal matrix proteins, they have been shown to be associated with the 
peroxisomal membrane. Two of these enzymes are tightly bound to the 
peroxisomal membrane: squalene synthase and cycloartenol-C-24-
methyltransferase. Oxidosqualene cyclase is not as strongly bound as the previous 
enzyme whereas squalene epoxidase is loosely bound to the peroxisomal 
membrane. It is possible that these enzymes become associated with the 
peroxisomal membrane after being imported into the peroxisomal matrix and this 
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requires a specific mechanism that has not been investigated.  However, one 
would assume that squalene sythase might be anchoring into the peroxisomal 
membrane via its possible C-terminus TM domain. Therefore, one could 
investigate the possible role of the TM domain by generating a truncated version 
of squalene synthase lacking the C-terminus TM domain but retaining the PTS1 
and analyzing the location of the truncated enzyme by immunoblot analysis. It is 
also not clear how cycloartenol-C-24-methyltransferase is associated with the 
peroxisomal membrane. However, one could assume that the N-terminal 
extension (114 amino acids) of Ddcycloartenol-C-24-methyltransferase may have 
a role in anchoring the enzyme into the peroxisomal membrane. Therefore, further 
research should be carried out to clarify the possible function of the N-terminal 
extension of DdSMT1. Overall, the association of these enzymes with the 
peroxisomal membrane indicates a significant role for peroxisomes in sterol 
biosynthesis in D.discoideum.       
Since squalene synthase, oxidosqualene cyclase and cycloartenol-C-24-
methyltransferase are membrane associated proteins in D. discoideum it was 
therefore necessary to investigate whether their putative PTS1 is functional. 
Although squalene synthase possesses the most efficient targeting signal (-SKL), 
it was found that this enzyme is still able to accumulate in the peroxisomes after 
deletion of its targeting signal. It is still unclear how squalene synthase is targeted 
to the peroxisome.  
By contrast, the putative PTS1 sequences of oxidosqualene cyclase and 
cycloartenol-C-24-methyltransferase have been shown to be responsible for 
targeting these two enzymes into the peroxisomes. Oxidosqualene cyclase ΔPTS1 
seems to associate with most cellular membranes. It is probable that cycloartenol 
synthase in D.discoideum, like the human lanosterol synthase, is a monotopic 
protein. Therefore, it is possible that, after deletion of the putative targeting signal, 
its amphipathic helix tends to insert into any membrane. Cycloartenol-C-24-
methyltransferase ΔPTS1 accumulated in the cytosol. This suggests that this 
enzyme does not contain a hydrophobic region and probably does not contain a 
TM domain. Based on this observation, it is possible that the association of this 
enzyme with the peroxisomal membrane occurs via the interaction of this enzyme 
with some peroxisomal membrane protein.    
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During this study the intracellular locations of the mevalonate pathway enzymes 
from HMG-CoA synthase have been determined in the unicellular organism 
D.discoideum. Our data clearly show that three of the pathway enzymes are 
peroxisomal and four enzymes are most likely cytosolic and one enzyme is 
localized to the ER. Furthermore, we determined the intracellular locations of the 
first five enzymes involved in converting farnesyl diphosphate to dictysterol in D. 
discoidium. It has been shown that the first four enzymes are peroxisomal and the 
fifth one was identified as an ER enzyme. This study provides a clear picture of 
the intracellular compartmentalization of the sterol biosynthesis enzymes in one 
organism. Further investigations will be needed to determine the reasons for the 
enzymes’ distribution between the different cellular compartments and to discover 
how the four of the sterol biosynthesis enzymes are bound to the peroxisomal 
membrane.  
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